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ABSTRACT 
 
Highly oxygenated, architecturally complex terpenoids constitute a biologically 
important class of natural products, yet their development into medicinally relevant 
analogs and effective biological probes are obstructed by their synthetic accessibility. 
Ryanodine is a unique diterpenoid that exhibits high affinity to a class of intracellular 
calcium ion channels bearing its name: ryanodine receptors. Structure-activity 
relationship studies have demonstrated how peripheral structural modifications affect 
binding affinity and selectivity among receptor isoforms, but to date have been limited to 
analogs prepared via chemical derivatization of natural material due to the intractability 
of total chemical synthesis.  
This thesis details synthetic efforts culminating in a total synthesis of ryanodol 
that proceeds in only 15-steps from commercially available (–)-pulegone. Early stage 
oxygen atom incorporation is strategically implemented to facilitate key, stereoselective 
carbon-carbon bond formation. In particular, a rhodium-catalyzed, intramolecular 
Pauson–Khand reaction is utilized to rapidly assemble the tetracyclic ABCD-ring system 
that constitutes the anhydroryanodol core. A novel, selenium-dioxide mediated oxidation 
to install three oxidation states and three oxygen atoms was discovered, enabling the 
rapid oxidative functionalization of the ryanodol A-ring. The modular route described 
herein allows for the preparation of synthetic structural analogs not readily accessible via 
chemical degradation, and is anticipated to enable rapid construction and evaluation of 
biologically active ryanodine analogs.  
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Chapter 1 
 
An Introduction to Ryania Natural Products 
 
 
 
 
 
 
1.1 INTRODUCTION  
 
In the nearly 70 years since its isolation, the natural product (+)-ryanodine (1, 
Figure 1) has inspired significant efforts towards understanding its structure, biological 
activity, and synthesis. Nearly three decades were required before the full details of its 
complex and highly caged structure were fully elucidated, whereas synthetic efforts have 
now spanned over half a century. The following chapter aims to summarize key aspects 
of its isolation, structure, biological activity, and to highlight efforts toward the synthesis 
of this synthetically intriguing diterpene. 
 
 
	  	  
Figure 1. The diterpenoid structures of (+)-ryanodine, ryanodol, and anhydroryanodol  
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1.2 ISOLATION AND STRUCTURE 
 
In 1948, Folkers and coworkers isolated a unique diterpenoid from the wet wood 
of the South American shrub Ryania speciosa Vahl. Ryania had long been of interest due 
to its biological activity in both insects and humans; extracts had historically been 
utilized as arrowhead poisons in Central and South America,1 and interest in powdered 
Ryania as a potent insecticide had been determined years earlier. Continuous extraction 
with chloroform, followed by repeated recrystallizations from diethyl ether afforded pure 
(+)-ryanodine (1), a compound found to have an insecticidal potency 700 times greater 
than crude extracts alone.2 Although a molecular formula in this original report was 
provided, a full structure of ryanodine could not be assigned with the physical data 
obtained at the time.  
	  
Figure 2. Key degradation studies and the structural elucidation of (+)-ryanodine and ryanodol 
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of structure elucidation by chemical degradation.3-9 In particular, two key observations 
proved critical not only for structural determination, but for subsequent synthetic work 
(Figure 2A): 1) ryanodine undergoes basic hydrolysis to liberate one equivalent of 
pyrrole-2-carboxylic acid and ryanodol (2), its deacylated congener; 2) both ryanodine 
and ryanodol undergo efficient fragmentation under acidic conditions giving rise to 
tetracyclic products, termed anhydroryanodine (4) and anhydroryanodol (3). An 
exhaustive set of degradation studies enabled Wiesner to propose that ryanodine 
possesses the structure shown in Figure 2B (5) bearing an isopropyl group on the convex 
face of the molecule. A subsequent X-ray crystal structure of a para-bromobenzyl ether 
derivative of ryanodol (6) was obtained in 1968 by Srivastava and Przybylska that 
corroborated all major structural features of Wiesner’s assignment with only the minor 
revision of the C2-stereocenter, instead placing the isopropyl group in the concave pocket 
of the molecule.10,11 This final confirmation of the structural identity of ryanodine led 
Wiesner to conclude that the biosynthetic origin was likely geranylgeraniol (9), which 
can be suggestively arranged to highlight that no significant rearrangements are necessary 
to generate the natural product (10).7,12 However, the specific order and nature of the 
bond forming events, as well as oxidations and oxygen-atom incorporations, remain 
unclear. 
 The ryanodane carbon numbering system (7), as well as the ring-lettering 
conventions (8), are illustrated in Figure 2C. Notably, of the five rings within its 
pentacyclic system, only the D-ring is oxygen bridged, with the remaining ABCE-rings 
all being carbocyclic in nature. From a structural standpoint, ryanodol bears an 
exceptionally caged and highly functionalized pentacyclic core, containing 11 contiguous 
Chapter 1 – An Introduction to Ryania Natural Products 4 
stereocenters and seven free hydroxyl moieties, one of which exists as part of an acidic 
hemiketal. Of these, the C3-oxygen bearing the pyrrole ester in ryanodine is sterically 
shielded within the concave AE ring system. The oxygenation of the molecule is largely 
distributed on one face of the 5-5-6, ABC-ring system, thus differentiating the two faces 
of the molecule as hydrophilic and hydrophobic. Indeed, ryanodol (2) itself is amphoteric 
in nature. It is soluble in both organic solvents and highly soluble in water; the extraction 
of ryanodol from an aqueous solution requires continuous extraction with refluxing 
chloroform over several days.2,9,13  
	  	  
Figure 3. A survey of ryanodane natural products varying in functionality and oxidation state  
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humans, such as the C3-deoxygenated natural products cinnzeylanol (11) and 
cinnzeylanine (12) from Cinnamomum,30 and 3-epiryanodol (15) from Persea.27-29,31  
 
1.3 BIOLOGICAL ACTIVITY AND RYANODINE RECEPTORS 
 
Although noted for its potent insecticidal activity,2 (+)-ryanodine bears historical 
significance as [3H]-1 was instrumental for the purification and characterization of 
ryanodine receptors (RyRs), a group of intracellular calcium ion channels present in 
skeletal muscle, cardiac muscle, as well as the brain.14,32,33 Ryanodine potently binds to 
RyRs with exceptionally high affinity, yet interestingly, exhibits concentration dependent 
effects: at nanomolar concentrations, 1 locks RyRs in an open, sub-conductance state,34 
whereas at higher concentrations, ryanodine causes closure of the channels.35 
In mammalian cells, these proteins exist in three isoforms (RyR1, RyR2, RyR3) 
with varying distributions dependent on the tissue type, and play a critical role in signal 
transduction, thereby mediating our movement and cognitive function.36,37 Mutations of 
RyRs are associated with numerous genetic diseases such as central core disease,38 
malignant hyperthermia,39 and catecholaminergic polymorphic ventricular tachycardia 
(CPVT).40 Furthermore, leaky hippocampal RyR2 channels have been demonstrated to 
contribute to stress-induced cognitive dysfunction,41 and altered expression of RyR2 and 
RyR3 have been implicated in the pathogenesis of neurodegenerative disorders such as 
Alzheimer’s disease.42,43 Given these implications, it has been suggested that these ion 
channels may serve as therapeutic targets for a range of diseases.44-47 
From a structural standpoint, it has been established that the pyrrole-2-carboxylate 
ester moiety is critical for high binding affinity in humans, and is the major orienting 
factor in binding to RyRs.48 A variety of structure activity relationship studies have been 
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conducted, exclusively through derivatization of material obtained from natural sources, 
and have demonstrated the ability to achieve binding selectivity amongst RyR isoforms 
via chemical modification of the molecular periphery.2 Despite these studies, to date, the 
precise mode of binding and the mechanism of channel modulation have not yet been 
fully determined. 
  
1.4 PRIOR TOTAL SYNTHESES OF (+)-RYANODOL 
 
1.4.1 Deslongchamps’s Total Synthesis of (+)-Ryanodol  
 
	  
Scheme 1. Relay studies by Deslongchamps (1979) on the reconversion of (+)-anhydroryanodol to 
(+)-ryanodol. 
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Although anhydroryanodol itself proved resistant toward C1-C2 olefin 
epoxidation, epianhydroryanodol (20), an isomer resulting from intramolecular 
translactonization, is readily epoxidized.  Noting this difference in reactivity between 
lactone isomers, it was established that by employing trifluoroperacetic acid under 
phosphate buffered conditions, equilibration to 20 could precede oxidation, enabling the 
direct synthesis of epianhydroryanodol epoxide (21) in excellent yield. Similarly, epoxide 
21 readily equilibrates to anhydroryanodol epoxide (22) under basic conditions. 
Subjection of either epoxide to Li(0)-metal in NH3 at –78 °C results in an intramolecular, 
reductive cyclization to provide ryanodol with a reported yield of 60%.  It is believed that 
in this final transformation, anhydroryanodol epoxide (22) is the on-path substrate, 
leading to productive cyclization, whereas premature reduction of epianhydroryanodol 
epoxide (21) results in the generation of carbonyl-reduction side products.13 
Simultaneous with studies assessing the viability of the conversion of 3 to 2 were 
synthetic efforts aimed at accessing anhydroryanodol (Scheme 2). To this end, a key 
Diel–Alder cycloaddition between enone 24, derived from (S)-carvone, and rac-
spirolactone 25 proceeded in quantitative yield to provide a mixture of diastereomeric 
Diels–Alder adducts. It was recognized that cleavage of the spirolactone under basic 
conditions results in ablation of the C4-stereocenter, resulting in convergence of isomers 
26a and 26n to the same 1,2-diketone intermediate (27). Thus, treatment of the isomeric 
mixture obtained from the Diels–Alder reaction with aqueous hydroxide resulted a 
diastereoconvergent, epimerization/aldol cascade, providing ketone 28. Further 
hydrolysis of the dioxolane moiety followed by basification effected an additional 
intramolecular aldol reaction, affording pentacyclic aldehyde 29 in 27% yield overall 
Chapter 1 – An Introduction to Ryania Natural Products 8 
from 24. Protection of the 1,2-diol and aldehyde moieties generated carbonate 30, which 
was elaborated via Baeyer-Villiger oxidation and tungsten-mediated de-epoxidation to 
olefin 31. Subjection under ozonolytic conditions with an acidic workup effected an 
intramolecular aldol cascade to forge the necessary 5-5-6 tricyclic ABC-ring system of 
ryanodol (33). 
	  	  	  
Scheme 2. The first total synthesis of (+)-ryanodol by Deslongchamps (1979) 
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thereby forming the key anhydroryanodol framework and establishing the ABCD 
tetracyclic framework (37).  Subsequent functional group adjustments and removal of the 
protecting groups provided (+)-anhydroryanodol in a total of 35 steps (longest linear 
sequence). Finally, conversion to (+)-ryanodol (2) was achieved by epoxidation and 
reductive cyclization as established in their relay protocol.  
 
1.4.2 Inoue’s Total Synthesis of (+)-Ryanodol and (+)-Ryanodine 
 
In 2014, Inoue and coworkers completed the second total synthesis of (+)-
ryanodol, capitalizing on latent C2-symmetry embedded within ryanodol’s congested 
pentacyclic core, a strategy first described by Sieburth and coworkers in 1994 (vide infra, 
Scheme 6) and others.59,60 The C2-symmetric building block 39, already constituting a 
functionalized ABE-ryanodol ring system, was prepared in 14-steps from commercially 
available starting materials, previously reported in an earlier publication.53-55 Treatment of 
39 with Co(acac)2, Et3SiH, and catalytic TBHP resulted in desymmetrization by olefin 
hydroperoxidation. A Kornblum DeLaMare rearrangement was then effected by 
treatment with NfF and DBU to provide triketone 41, that spontaneously hydrates on 
silica to generate hemiketal 42. Protection of the hemiketal as its benzyl ketal (43), 
followed by generation of the thiocarbonate moiety, results in a handle for generation of a 
stabilized, carbon-based radical. Construction of the ryanodol C-ring was subsequently 
effected in six steps via installation of two tethered alkenes and a ring-closing metathesis 
reaction utilizing the 2nd generation Hoveyda-Grubbs catalyst, in the process completing 
the preparation of the full pentacyclic ABCDE-ring system (47). A series of functional 
group manipulations then provided 1,2-diketone 49, which underwent a sluggish but 
Chapter 1 – An Introduction to Ryania Natural Products 10 
selective 1,2-addition reaction with 2-propenyllithium to install the final three-carbon 
unit in 21% yield over two steps. Finally, an additional four synthetic steps enabled the 
removal of the necessary protecting groups to provide (+)-ryanodol in a total of 35-steps 
(longest linear sequence). 
	  	  
Scheme 3. An approach to (+)-ryanodol based on latent C2-symmetry by Inoue (2014) 
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protecting groups, one benzyl protecting group, and one acetyl protecting group, to afford 
protected ryanodol 53 and leaving only the C3-alcohol accessible. Acylation was 
subsequently achieved with Yamaguchi’s reagent in conjunction with protected glycine 
54 and transformed to the carboxypyrrole derivative via cyclocondensation with 
tetrafluoroborate salt 56. Finally, removal of the protecting groups was effected in three 
steps to provide (+)-ryanodine. The implementation of this study subsequently informed 
the choice of protecting groups necessary to intercept previously described synthetic 
intermediates in their prior total synthesis of (+)-ryanodol, thus enabling the first total 
synthesis of (+)-ryanodine, proceeding in 42 total steps.57 
	  	  
Scheme 4. A ten step conversion of (+)-ryanodol to (+)-ryanodine by Inoue (2016) 
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congested pentacyclic framework of ryanodol and educated the design of synthetic work 
in this area. 
 
1.5.1  Wiesner’s Approach to Anhydroryanodol 
 
An early report of a model system toward the anhydroryanodol framework was 
published by Wiesner in 1972 (Scheme 5), utilizing a key, oxidation-triggered 
rearrangement to build the BCD-ring system.62 Starting from benzonorbornadiene (58), 
tetracyclic olefin 59 was treated with N-chlorosuccinimide in acetic acid, resulting in a 
1,2-aryl shift to generate chloroacetate 61. Selective displacement of the chloride moiety 
with Et4NOAc in DMF afforded bisacetate 62, which could be selectively saponified and 
subsequently oxidized using Jones reagent to afford tetracyclic ketone 63. Late stage 
Baeyer-Villiger oxidation then affords the corresponding lactone 64, generating a 
structure that maps well onto the anhydroryanodol BCD-ring system.  
	  	  
Scheme 5. Wiesner’s rearrangement approach to the anhydroryanodol BCD-ring system. 	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C2-symmetry present within the diterpenoid framework (Scheme 6).63 Notably, 
identification of this hidden symmetry element was the central strategy within Inoue’s 
subsequent total synthesis published in 2014 (see Scheme 3),53-55,58 and similarly pursued 
by other laboratories.59,60 Condensation of dimethylacetonedicarboxylate (65) with 
glyoxal resulted in the C2-symmetric, tetraester 66, which could be methylated under 
mild conditions to afford a 1:1 mixture of meso- to rac- substrates 67 and 68. Krapcho-
type decarboxylation under acidic conditions, followed by 1,2-carbonyl reduction and 
protection of the resulting secondary alcohols as their MOM-ethers provided diester 71. 
A key acyloin condensation employing Na(0)-metal in the presence of TMSCl resulted in 
bis(trimethylsiloxy)alkene 72, establishing a deoxygenated ABE-ring system within 
ryanodol. 
	  	  
Scheme 6. A C2-symmetric approach to ryanodol’s ABE-ring system by Sieburth (1994) 
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1.5.3 Wood’s Phenolic Oxidation Approach to Ryanodol 
 
	  	  
Scheme 7. A phenolic oxidation approach to the BC-ring system by Wood (2003) 
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1.6 CONCLUDING REMARKS 
 
Ryanodine, ryanodol, and related natural products have inspired numerous studies 
in the nearly 70 years since ryanodine’s isolation, ranging from chemical structure 
elucidation to protein purification of the RyR calcium ion channels. By understanding the 
structure, activity, and synthesis of this challenging diterpenoid natural product, 
considerable insights have been gained in a number of interdisciplinary fields. Within the 
context of chemical synthesis, the novel molecular architecture has not only uncovered 
important aspects of the reactivity of these molecules, but also motivated the design of 
new synthetic methods and approaches to complex molecule synthesis. It is clear from 
these studies that continued interest in and attention to this remarkable class of 
polyoxygenated molecules will inspire the development of new synthetic methods. 
Ultimately, it is anticipated that a truly practical and efficient preparation of (+)-
ryanodine and related analogs will be accessible via de novo chemical synthesis. 
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Chapter 2 
 
Total Synthesis of (+)-Ryanodol 
 
 
2.1 INTRODUCTION  
The potent biological activity and unique structure of (+)-ryanodine (1) prompted 
our laboratory in 2011 to begin synthetic investigations toward this diterpenoid natural 
product, with the goal of executing a practical and enantioselective synthesis. Numerous 
synthetic approaches were attempted in order to construct the sterically congested and 
richly decorated ryanodane framework, which, along with model studies, are 
schematically summarized in Appendix 3. This chapter describes a successful and 
optimized total synthesis of (+)-ryanodol from the commercially available monoterpene 
(S)-pulegone, proceeding in only 15-steps. It is anticipated that the strategic blueprint 
detailed within this chapter will enable the future preparation of numerous Ryania natural 
products including (+)-ryanodine, and serve as the basis for detailed structure-activity 
relationship studies for the identification of potent synthetic ryanoids.  
 
2.1.1 Structure and Synthetic Challenges 
From a structural standpoint, ryanodol possesses numerous synthetic challenges. 
Embedded within its highly caged, pentacyclic core are 11-contiguous stereocenters, two 
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of which are all-carbon quaternary centers, and possesses seven free hydroxyl moieties. 
In the absence of these hydroxyl groups, the carbocyclic core itself presents a formidable 
challenge; the 5-5-6, ABC-ring system is spanned by a two-carbon bridge constituting the 
E-ring, and an oxygen bridge forming the D-ring. The C2-isopropyl group is buried 
within the concave face of the AE-pocket, creating a highly congested environment for 
the C3-alcohol. Further analysis reveals that the high level of oxidation and specific 
oxygen atom placement is nontrivial. Perhaps best stated by Deslongchamps after a 
similar structural analysis, “It can be concluded from this analysis that ryanodol is indeed 
a very complex diterpene in which only three carbons of the skeleton are left 
unfunctionalized as methylene groups.”1 
	  
Figure 1. The structure and synthetic challenges of (+)-ryanodol 	  
2.1.2 Retrosynthetic Analysis 
Considerable revisions to our initial retrosynthetic analysis were performed in an 
effort to continuously improve and evaluate multiple synthetic strategies. Extensive route 
scouting and optimization were necessary to arrive at the approach described within this 
chapter, with the pursuit of numerous unsuccessful avenues necessary for educating the 
specific design herein.  
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Guided by the landmark studies of Deslongchamps and coworkers,1-5 our final 
retrosynthetic analysis posited that the C1-C14 bond of ryanodol (2) was, in fact, the 
most simplifying and strategic retrosynthetic disconnection, in turn revealing tetracyclic 
anhydroryanodol as an initial synthetic target (Scheme 1). Envisioning that late-stage 
introduction of the isopropyl group could occur through a transition metal-catalyzed 
cross-coupling reaction of vinyl triflate 80, we anticipated that the requisite A-ring 
oxidation pattern could be accessed via chemo- and stereoselective functionalization of 
cyclopentenone 81, whereby the enone would provide a functional group handle to install 
the critical C3, C4, and C12 alcohols of 2. Enone 81 was expected to be accessible via an 
intramolecular Pauson–Khand reaction, a transformation that we expected to be 
facilitated by the conformational rigidity of bicyclic lactone 82. In turn, it was thought 
that the lactone moiety would be prepared from an appropriately functionalized 
cyclohexane building block (83), accessible from a simple monoterpene unit such as the 
commercially available (S)-pulegone (84). By this analysis, the oxygen atoms at C6, C10, 
and C11 would be incorporated early in the synthesis, while the oxygen atoms at C3, C4, 
and C12 would be introduced at a late stage. With the implementation of appropriate 
protecting groups, we anticipated that this strategy would minimize unnecessary synthetic 
redox manipulations, resulting in a concise step count. 
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Scheme 1. Retrosynthetic analysis of (+)-anhydroryanodol 	  
2.2 FORWARD SYNTHETIC EFFORTS 
2.2.1 Oxidation Studies of (S)-Pulegone 
Our studies commenced with the appropriate functionalization of (S)-pulegone, a 
commercially available monoterpene unit conveniently prepared on decagram scale by 
the procedure of Corey and Suggs.6 Given our retrosynthetic analysis, it was envisioned 
that early stage C6- and C10-hydroxyl incorporation should be performed at the earliest 
stage possible in the synthesis. In light of this assessment, it was determined that 
pulegone could be stereoselectively functionalized in five steps to afford oxygenated 
ketone 90, possessing a range of potential protecting groups. In this sequence, pulegone is 
first epoxidized under nucleophilic conditions to provide epoxyketone 85. Tedious and 
repetitive chromatographic separation of the diastereomeric epoxides enables isolation of 
pure 85,7 typically in 20-35% isolated yield after additional recrystallization. Acid-
mediated isomerization and protection provides ketone 87,8 which can be subsequently 
oxidized through treatment with KHMDS and Davis oxaziridine 88.9 A final protection 
provides 90 in five chemical steps, in total requiring several chromatographically 
challenging separations and offering limited material throughput.  
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Scheme 2.  Initial route for the preparation of protected ketone building block 90. 	  
 Positing that a more efficient approach should be feasible, we hypothesized that 
the C6-oxidation state might also be directly installed via enolate oxidation (Scheme 3). 
Treatment of (S)-pulegone at –78 °C with 0.95 equiv KHMDS followed by warming to 0 
°C for 1h enabled efficient equilibration to the thermodynamic, potassium enolate (94), 
which could be oxidatively trapped at C6, providing a 2.5 : 1 mixture of diastereomeric 
alcohols. Next, noting the apparent compatibility of Davis oxaziridine 88 with excess 
KHMDS, we hypothesized that a one-pot protocol to simultaneously install both the C6- 
and C10-alcohols in a single step might be possible. Indeed, treatment of 84 with 2.5 
equiv of KHMDS at –78 °C followed by dropwise addition of 2.4 equiv of 88 provided 
α,α’-diol 91, which could be isolated as a single diastereomer in 42% yield on 120 mmol 
scale. Although the yield is modest, we note that in a single transformation, a simple 
terpene is converted to a valuable building block possessing the requisite ryanodol C-ring 
oxidation pattern. Further investigations revealed that the efficiency of this 
transformation could be improved to 50% yield by initial equilibration to the 
thermodynamic enolate (94) and use of toluene as a cosolvent. However, given the 
operational simplicity of the former procedure on larger scales, this protocol was 
preferentially employed for increased material throughput. A screen of oxaziridines 
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varying in substitution and parent structure did not reveal improved yields;10-12 in 
particular, oxaziridines bearing acidic α-protons were not compatible with this one pot 
protocol.12 
 Notably, the difference in reactivity of the secondary and tertiary alcohols of 91 
are pronounced; selective monoprotection of the C10-alcohol is readily achieved under 
mild conditions, whereas more forcing conditions enable protection of the C6-tertiary 
alcohol. Seeking a mild protecting group for elaboration in our studies, diol 91 was 
readily bisprotected by treatment with excess benzyl chloromethyl ether in the presence 
of di-iso-propylethylamine and tetrabutylammonium iodide to provide ketone 92 in 65% 
yield. 
 
	  
Scheme 3. A direct, bishydroxylation of pulegone via double enolate oxidation 	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2.2.2 Synthesis of the D-Ring Lactone 
At this stage, preparation of the D-ring lactone became the focus of our studies. 
To this end, addition of propynylmagnesium bromide to 92 at 0 °C proceeded in 5:1 dr, 
providing the equatorially-disposed alkyne in 81% isolated yield. It is notable that the 
C10-secondary ether results in significant improvements in the diastereoselectivity of this 
addition. Model substrates lacking the C10-oxidation state result in a nearly non-selective 
process, giving rise to an equal mixture of axial and equatorial alkyne adducts. 
Ozonolytic cleavage of the 1,1-disubstituted olefin proceeded in excellent yield to afford 
methyl ketone 94; the use of methanol cosolvent in this transformation was found to be 
critical to avoid deleterious C5-C6 bond fragmentation13 that precluded high yields. With 
the β-hydroxyketone established, it was initially envisioned that lactone synthesis could 
be achieved via application of an N, N’-dicyclohexylcarbodiimide-mediated 
phosphonoacylation/intramolecular Horner–Wadsworth–Emmons lactone synthesis.14,15 
This approach, known to be particularly effective for hindered tertiary alcohols, had 
proven serviceable in model studies lacking C10-oxidation. Unfortunately, 94 proved 
resistant to acylation under a number of conditions. Presumably, the increased steric 
encumbrance and inductively withdrawing C10-ether dramatically decreases the 
nucleophilicity of the tertiary alkynol. Instead, an alternative protocol was established, in 
which ketone 94 was first converted to diyne 97 via addition of ethoxyethynylmagnesium 
bromide, and subsequently converted to the α,β-unsaturated lactone via a AgOTf-
mediated cyclization/elimination cascade.16 
It was envisioned that the newly formed α,β-unsaturated lactone moiety could 
serve as an excellent electrophile for a carbon based nucleophile, and that construction of 
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one of the all-carbon quaternary centers might be achieved via the reliable addition of  an 
appropriate cuprate. Indeed, treatment of 96 with vinylmagnesium bromide (6.0 equiv) in 
the presence of CuI (3.0) at cryogenic temperatures (–78 to –30 °C) effected a smooth 
1,4-conjugate vinylation, providing a single diastereomer of 98 in 84% yield. 
Importantly, the establishment of this critical all-carbon C5-quaternary center provides a 
uniquely rigid bicyclic framework that enforces the proximity of the olefin and alkyne in 
a 1,3-diaxial fashion. By design, it was expected that the geometrical constraints imparted 
by the rigid framework should enable both an efficient and stereoselective intramolecular 
Pauson–Khand reaction. 
 
Scheme 4. Preparation of the CD-bicyclic ring system 
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2.2.3 Synthesis of the ABCD-Ring System  
The preparation of the critical enyne 98 subsequently allowed for the evaluation 
of a key, intramolecular Pauson–Khand reaction, which was envisioned to deliver the 
ABCD-ring system of anhydroryanodol while providing a useful cyclopentenone moiety 
for further functionalization of the A-ring. A number of Pauson–Khand procedures were 
screened for high yield and diastereoselectivity (Table 1). Although standard conditions 
utilizing stoichiometric amounts of Co2(CO)817,18 produced the desired product, 
separation of diastereomeric enones 99a and 99b proved challenging and indicated that a 
more selective protocol was necessary. Monometallic mediators were found to improve 
the dr, with Mo(CO)3(DMF)318 providing 99a as a single diastereomer in 67% yield. 
Despite the serviceable yield and scalability of this transformation, we sought a more 
efficient protocol that could obviate the need for stoichiometric metals and their resulting 
byproducts. With this in mind, we were pleased to find that treatment of 98 with 1 mol% 
[RhCl(CO)2]219 under an atmosphere of carbon monoxide provided the desired product in 
85% yield, again as a single diastereomer. Excitingly, the realization of this key Pauson–
Khand reaction enables the efficient preparation of the ABCD-tetracycle in only eight 
steps from commercially available materials, providing multi-gram quantities of this key 
intermediate. Structural and stereochemical confirmation was provided both by rigorous 
NMR spectroscopic techniques, but furthermore, was unambiguously assigned via single 
crystal X-ray diffraction analysis of 99a. 
  
Chapter 2 – Total Synthesis of (+)-Ryanodol 31 
Table 1. Evaluation of reaction parameters for an intramolecular Pauson–Khand reaction 	  
 
 
entry conditions drb yield (%)c 
1 Co2(CO)8 (1.2 equiv), THF, 12 h; then DMSO, 65 °C 2.2 : 1 46 
2 Co2(CO)8 (1.2 equiv), CH2Cl2, 9 h; then NMO, 23 °C 4.5 : 1 78 
3 Mo(CO)6 (1.2 equiv), DMSO, PhMe, 110 °C -- trace 
4 Mo(CO)3(DMF)3 (1.1 equiv), CH2Cl2, 23 °C > 20 : 1 67 
5 [RhCl(CO)2]2 (1 mol %), CO (1 atm), m-xylene, 110 °C >20 : 1 85 
 
a Reactions conducted on 0.2 mmol scale. b Determined by 1H NMR of the mixture of diastereomers.  
c Isolated yield after purification by silica gel chromatography. 
 
 
 
 
2.2.4 Selenium Dioxide Mediated A-Ring Functionalization 
The realization of our key Pauson–Khand cyclization led us to the next phase of 
our synthetic studies; specifically, chemo- and stereoselective functionalization of the A-
ring through the introduction of the C3, C4, and C12-alcohols as well as the C2-isopropyl 
unit were anticipated to present formidable challenges. Indeed, initial forays into 
functionalization of the C4-H methine were immediately frustrated by undesired 
reactivity; established methods for allylic oxidation via generation of reactive radical 
species (e. g. Pd[OH]2/TBHP,20 Rh2(cap)4/TBHP21, Cr[V]-species22) were unfruitful due 
to competitive functionalization of the C1-C12 olefin (e. g. epoxidation, 1,2-
difunctionalization), while more forcing conditions typically led to nonselective oxidative 
fragmentation of the cyclopentenone. Although we entertained the possibility of 
advancing these unanticipated products further in the synthesis, it was unclear how 
transposition of the requisite oxidation pattern could be efficiently achieved.  
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Scheme 5. Initial discovery of a remarkable selenium dioxide mediated oxidation reaction 
In continued attempts to directly functionalize the C4-position via non-radical 
based allylic oxidations, highly forcing conditions utilizing SeO2 at significantly elevated 
temperatures were screened. Fortuitously, it was discovered that treatment with a large 
excess of SeO2 in the presence of phosphate buffer at 160 °C for 15 minutes resulted in 
the isolation of a new, oxidized product (Scheme 5). Rigorous structural assignment of 
this compound revealed it to be the fully oxidized diosphenol 100, a compound 
possessing the C4, C12 syn-vicinal diol of 2. This astonishing single-step transformation 
installs the necessary oxygen atoms at C3, C4, and C12 while simultaneously providing a 
functional handle for incorporation of the C2-isopropyl group. In contrast, at lower 
temperatures in the presence of SeO2, diosphenol 102 is the predominant product, lacking 
the C4-oxidation state, but still effecting a formal Riley oxidation23 and hydration of the 
C1-C12 olefin. 
Since C4-deoxy analogs of ryanodine are themselves natural products and of 
potential interest for future biological studies,24,25 we optimized procedures to prepare 
both 100 and 102 (Scheme 6). Due to concerns that contamination by 1H NMR silent, red 
selenium byproducts resulted in artificially inflated isolated yields, our optimization 
efforts were guided by 1H NMR yields determined by integration versus an external 
standard, and isolated yields were determined after conversion to corresponding vinyl 
triflates 103 and 104, which could be obtained as analytically pure compounds.  Thus, 
subjection of tetracycle 99a to 10 equiv of SeO2 in wet 1,4-dioxane at 110 °C for 1 h 
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provided 102 in 67-69% 1H NMR yield, and the corresponding vinyl triflate 103 in 56% 
isolated yield over two steps. Alternatively, treatment of 99a with 10 equiv of SeO2 in 
anhydrous 1,4-dioxane in the presence of freshly activated 4Å MS at 110 °C for 9 h 
provided 100 in 33-35% 1H NMR yield, and vinyl triflate 104 in 28% isolated yield over 
two steps. Despite the modest yield, this reaction accomplishes the stereospecific 
incorporation of three oxygen atoms, proceeds with an average efficiency of 
approximately 70% yield per transformation, and fares well in comparison to conceivable 
multistep protocols to achieve the same reactivity.  
The complexity of this transformation warrants a few additional comments. 
Formally, 100 can be thought to arise by oxidation to the α-diketone, hydration of the 
enone, and C–H oxidation of the C4 methine (Scheme 6A). Although the precise 
mechanism remains unclear at this time, a few observations are relevant: 1) reactions 
conducted under rigorously anhydrous conditions still result in formation of 102, 
suggesting that the C12-alcohol may be incorporated directly from SeO2, rather than 
water; 2) reactions run under rigorously deoxygenated conditions inside a nitrogen-filled 
glovebox provide 100 in comparable yield, an observation that is inconsistent with the 
C4-alcohol arising from aerobic oxidation; 3) reactions run to low conversion result in 
isolation of diosphenol 102 with very little detection of 100, suggesting that C4-
hydroxylation occurs in a downstream event; 4) Resubjection of diosphenol 102 to the 
reaction conditions results in sluggish conversion to 100, suggesting that the final C4 
oxidation might proceed through non-isolated intermediate. Further mechanistic 
investigations of this reaction are ongoing and should aid the development of a more 
efficient protocol.   
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 Furthermore, the rapid elaboration of the ryanodane A-ring to provide vinyl 
triflates 103 and 104 offers a potentially important diversification point for the study of 
ryanodane derivatives. The presence of a valuable functional group handle in the vinyl 
triflate enables not only additional functionalization to access the natural product, but 
enables diversification by cross-coupling, and could serve as a versatile precursor to 
assess the biological activity of ryanodine analogs varying in substitution at this position. 
 
Scheme 6. The effect of water on the selenium-dioxide mediated oxidation of the enone 99a 	  
2.2.5 Synthesis of (+)-Anhydroryanodol 
With an established protocol for the preparation of the highly functionalized vinyl 
triflate 104, advancement to (+)-anhydroryanodol only necessitated installation of the C2-
isopropyl unit, 1,2-enone reduction, and removal of the benzyloxymethyl protecting 
groups. Although we briefly evaluated direct methods to install the C2-isopropyl group 
via Negishi-coupling with isopropylzinc reagents,26 or Stille-coupling with the more 
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reactive, 2-propylazastannatrane,27 we ultimately opted for coupling of a 2-propenyl 
group with the expectation that hydrogenolysis of the two benzyloxymethyl-protecting 
groups could concurrently effect selective olefin hydrogenation. Thus, palladium-
catalyzed cross-coupling between 104 and tributyl(2-propenyl)stannane installed the final 
three carbons, delivering 105 in 64% yield.  
Efforts to elaborate 105 via stereoselective 1,2-reduction were initially met with 
poor reactivity. Treatment with NaBH4 in MeOH, with or without added CeCl3•7H2O 
resulted in sluggish carbonyl reduction, instead rapidly reacting with the 1,2-diol moiety 
to generate the corresponding boronic ester.  Turning to more reactive conditions, it was 
found that LiBH4 cleanly effected 1,2-reduction, delivering the C3 alcohol with only 
partial borate formation that was readily removed through rapid treatment with KHF2 
during workup. Without additional purification, alcohol 106 was subsequently treated 
with H2 in the presence of Pd(OH)2/C in ethanol to cleanly promote removal of the 
benzyloxymethyl groups as well as effect alkene hydrogenation, delivering 
anhydroryanodol (3) in 61% yield over 2 steps. As Deslongchamps and coworkers have 
demonstrated the ability to synthesis (+)-ryanodol from (+)-anhydroryanodol,5 
completion of this synthetic sequence constitutes a formal total synthesis of 2. Notably, 3 
is prepared from commercially available starting materials in only 13 steps with excellent 
material throughput.  
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Scheme 7. Palladium catalyzed cross-coupling and advancement to (+)-anhydroryanodol 	  
2.2.6 Conversion of (+)-Anhydroryanodol to (+)-Ryanodol 
The successful development of a route to access (+)-anhydroryanodol left only 
two transformations to complete the total synthesis of 2, namely, epoxidation of the C1-
C2 olefin and reductive cyclization under dissolving metal conditions. Although 
reproduction of the protocol described by Deslongchamps and coworkers appeared 
straightforward at first, considerable efforts were required to reproduce and reoptimize 
the final step of this two-step protocol.5 
Slight modifications of the epoxidation conditions were first explored in an 
attempt to circumvent the use of hazardous 90% hydrogen peroxide, a reagent known to 
spontaneously detonate during distillation.28 Instead, simple application of a known 
protocol employing urea hydrogen peroxide adduct enabled a convenient and safe 
alternative for the preparation of trifluoroperacetic acid solution.29 Treatment of 3 with 
freshly prepared trifluoroperacetic acid (3 equiv) in the presence of HNa2PO4 (6 equiv) 
for 3 hours enabled the clean conversion of 3 to translactonized epoxide 21, in nearly 
identical yield to that reported by Deslongchamps.   
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Subjection of this material to Li(0) in NH3, freshly distilled from  sodium metal at 
–78 °C, resulted in reductive cyclization to produce (+)-2 in 38% yield (lit. 60% yield) 
after isolation by continuous extraction and silica gel chromatography. In our hands, the 
reaction profile was highly dependent on the purity of the ammonia. Independent control 
reactions conducted with ammonia condensed directly from the gas cylinder, or utilizing 
redistilled ammonia with added H2O (10 equiv), or exogenous Fe-salts revealed that these 
parameters all significantly affect the ratio of 2 to previously identified carbonyl-
reduction products in addition to minor, unidentified degradation products. More 
specifically, the addition of exogenous H2O resulted in nearly complete carbonyl 
reduction, whereas the addition of Fe-salts resulted in reduced reactivity and the 
formation of a new product. The significant effect of ferrous impurities from ammonia 
storage in iron based gas cylinders has been well documented in the context of Birch 
reductions.30 In this context, iron-based impurities may rapidly catalyze lithium amide 
formation, thereby negatively affecting productive reductive cyclization and instead 
promoting a variety of non-productive, base-mediated decomposition pathways. 
The modest 38% yield obtained in this report represents the highest reproducible 
yield in our hands, and is more consistent with initial, unoptimized yields obtained by 
Deslongchamps from an earlier report (lit. 30-35% yield).31 At this juncture, we believe 
that the inability to reproduce the reported 60% yield by Deslongchamps and coworkers 
may be attributed to additional unidentified reaction parameters or trace metal impurities 
that may potentially promote or inhibit the desired cyclization. Further investigations into 
the nature of these additional parameters will likely enable the identification of an 
improved protocol.  
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Scheme 8. Reductive cyclization of (+)-anhydroryanodol to (+)-ryanodol 	  	  
2.3 CONCLUDING REMARKS 
In summary, a concise and enantiospecific total synthesis of (+)-ryanodol has 
been accomplished, proceeding in 15 steps from commercially available starting 
materials. A schematic summary is presented in Scheme 9. The development of this final 
optimized route was enabled by extensive prior strategic investigations and 
considerations that illustrated the ability to rapidly assemble the ABCD-tetracycle by an 
intramolecular Pauson–Khand approach. Notable synthetic achievements of the route 
described above include, 1) the stereospecific oxidative functionalization of (S)-pulegone 
to directly arrive a versatile building block; 2) application of a Ag-catalyzed lactone 
synthesis for the preparation of the highly functionalized AD-ring system; 3) an efficient 
and diastereoselective, Rh-catalyzed, intramolecular Pauson–Khand to prepare the 
complex ABCD-ring system of anhydroryanodol; 4) discovery of a novel selenium-
dioxide oxidative functionalization to install three oxidation states and three oxygen 
atoms and generate a fully functionalized A-ring. Furthermore, the synthesis described 
herein constitutes a significant advance when compared to the state-of-the-art in the 
preparation of these complex diterpenoids, requiring nearly 20 fewer steps than previous 
efforts.32 
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 The synthetic strategy employed in this total synthesis of (+)-ryanodol is 
anticipated to significantly enable the preparation of a diverse array of ryanodane natural 
products, as well as an array of structural ryanodane analogs. Indeed, multiple 
opportunities for structural diversification at a late stage, as well as early stage 
modifications, to systematically study the effect of specific oxygen-atoms, are entirely 
accommodated by the synthetic strategy described herein. Efforts in this vein are the 
current focus of ongoing studies within our laboratory. 
 
	  
Scheme 9. Complete synthetic sequence. 	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2.4 EXPERIMENTAL SECTION 
2.4.1 Materials and Methods 
Unless otherwise stated, reactions were performed under an inert atmosphere (dry N2 
or Ar) with freshly dried solvents utilizing standard Schlenk techniques. Glassware was 
oven-dried at 120 °C for a minimum of four hours, or flame-dried utilizing a Bunsen 
burner under high vacuum. Tetrahydrofuran (THF), methylene chloride (CH2Cl2), 1,4-
dioxane, and toluene (PhMe) were dried by passing through activated alumina columns. 
2-Methyltetrahydrofuran (anhydrous, >99%, inhibitor-free) and m-xylene (anhydrous, 
>99%) were purchased from Sigma-Aldrich and stored under argon. Absolute ethanol 
(200 Proof) was purchased from Koptec. Methanol (HPLC grade) was purchased from 
Fisher Scientific. 1,2-Dichloroethane was purified via distillation over calcium hydride 
immediately before use. Anhydrous ammonia (NH3) was purchased from Matheson Tri-
Gas and distilled over sodium metal prior to use. Triethylamine (Et3N) and N,N-
diisopropylethylamine (i-Pr2NEt) were distilled over calcium hydride prior to use. All 
reactions were monitored by thin-layer chromatography using EMD/Merck silica gel 60 
F254 pre-coated plates (0.25 mm) and were visualized by UV (254 nm), p-anisaldehyde, 
or KMnO4 staining. Flash column chromatography was performed using silica gel 
(SiliaFlash® P60, particle size 40-63 microns [230 to 400 mesh]) purchased from 
Silicycle. 1H and 13C NMR spectra were recorded on a Varian Inova 500 (at 500 MHz 
and 126 MHz, respectively) and are reported relative to internal CHCl3 (1H, δ = 7.26) or 
CD2HOD (1H, δ = 3.31), and CDCl3 (13C, δ = 77.0), CD3OD (13C, δ = 49.0). Data for 1H 
NMR spectra are reported as follows: chemical shift (δ ppm) (multiplicity, coupling 
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constant (Hz), integration). Multiplicity and qualifier abbreviations are as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, app = apparent. IR 
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in 
frequency of absorption (cm–1). HRMS were acquired using an Agilent 6200 Series TOF 
with an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric 
pressure chemical ionization (APCI), or mixed (MM) ionization mode. Optical rotations 
were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell at 589 
nm. 
Reagents were purchased from commercial vendors or prepared as follows:  Solid 
potassium hexamethyldisilazide (KHMDS, 95%) was purchased from Sigma-Aldrich and 
stored in a nitrogen-filled glovebox. Potassium hexamethyldisilazide solution (0.5 M in 
PhMe) was purchased from Sigma-Aldrich and stored under Argon. Rac-3-phenyl-2-
(phenylsulfonyl)-1,2-oxaziridine (Davis Oxaziridine) was prepared according to literature 
procedures. Chloromethyl benzyl ether (BnOCH2Cl) was prepared from 
paraformaldehyde, benzyl alcohol, and gaseous hydrogen chloride according literature 
procedures.33 Propynylmagnesium bromide (0.5 M in THF) was purchased from Alfa 
Aesar or freshly prepared via direct deprotonation of propyne with ethylmagnesium 
bromide (1 M in THF). Ethoxyacetylene (50 wt % in hexanes) was pu9rchased from GFS 
Chemicals and used as received. Silver triflate (AgOTf, 99%), selenium dioxide (SeO2, 
99.8%), and chlorodicarbonyl rhodium (I) dimer ([RhCl(CO)2]2) were purchased from 
Strem Chemicals and stored in a nitrogen-filled glovebox. N-(5-Chloro-2-
pyridyl)bis(trifluoromethanesulfonimide) (Comins Reagent) was purchased from 
Oakwood Chemicals. Copper(I) iodide (CuI) and palladium hydroxide on Carbon 
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(Pearlman’s Catalyst, 20 wt % on C) were purchased from Alfa Aesar. LiBH4 (>95%) 
and lithium (wire stored in mineral oil, 99.9% trace metal basis) were purchased from 
Sigma-Aldrich. 
 
 
 
 
2.4.2 Experimental Procedures 
Notes on the preparation of Diol 91: Both the selectivity and yields obtained for 
the α,α’-bishydroxylation of pulegone were finely dependent on the quality of KHMDS 
utilized in the reaction, as well as precise temperature control. Improved selectivities and 
yields were more readily obtained on smaller scale (50% yield, 10 mmol scale) for the 
preparation of diol 91 via pre-equilibration of the potassium enolate at 0 °C to the 
thermodynamically-preferred, conjugated dienolate, as well as utilizing KHMDS (0.5 M) 
in PhMe solution. However, in order to improve material throughput on scale, a 
simplified protocol was established for larger scale (42% yield, 120 mmol scale) at the 
slight cost of reaction efficiency.  
Additionally, separation of the diastereomeric products was improved via use of 
wet silica gel, prepared as follows: Silica gel (SiliaFlash® P60, particle size 40-63 
microns [230 to 400 mesh], purchased from Silicycle, 950 g) was slowly mixed with 
deionizied water (50 mL) in a 1-liter media bottle. The silica was then vigorously shaken 
for five minutes, and then allowed to equilibrate for 12 h before use as normal for silica 
gel purification. The product obtained by this method was typically 97% pure by 1H 
NMR analysis, containing some minor oxaziridine-derived products. 
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Preparation of Diol 91 (10 mmol scale): 
 
 To a flame-dried, 250-mL, round-bottomed flask equipped with a magnetic stirbar 
was added (S)-pulegone (1.52 g, 10.0 mmol, 1.0 equiv) and THF (50 mL). The solution 
was cooled to –78 °C in a dry ice/acetone bath and KHMDS (19.0 mL, 0.5 M solution in 
PhMe, 9.50 mmol, 0.95 equiv) was added dropwise by cannula transfer over 10 minutes. 
After completion of the transfer, the dry ice/acetone bath was replaced with an ice/water 
bath, and the flask was stirred at 0 °C for 1 h. The solution was then recooled to –78 °C 
in a dry ice/acetone bath, and additional KHMDS solution (31.0 mL, 0.5 M solution 
PhMe, 15.5 mmol, 1.55 equiv) was added rapidly via cannula transfer and the flask 
stirred for 15 minutes to ensure complete cooling of the solution. A solution of rac-3-
phenyl-2-(phenylsulfonyl)-1,2-oxaziridine (6.31 g, 24.0 mmol, 2.4 equiv) in THF (400 
mL) was then added dropwise by cannula transfer over the course of 1 h, producing a 
deep orange-red solution that was stirred for 15 minutes. It is critical that the enolate 
solution is efficiently stirred during the addition to maintain a consistent internal 
temperature. Sat. aq. NH4Cl (90 mL) was then added and the flask allowed to warm to 
ambient temperature and stirred for 1 h, until TLC-analysis indicated complete hydrolysis 
of the imine byproduct (N-benzylidenebenzenesulfonamide). The resulting mixture was 
extracted with EtOAc (150 mL), washed with sat. aq. NH4Cl (2 x 150 mL), and the 
combined aqueous layers extracted with EtOAc (200 mL). The combined organic layers 
were washed with brine (200 mL), dried over anhydrous MgSO4, filtered and 
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concentrated in vacuo. Purification by silica gel chromatography (20 to 30 to 40% EtOAc 
in hexanes) on wet silica gel (see above) affords diol 91 as a white solid (923 mg, 5.01 
mmol, 50% yield). 
 
Preparation of Diol 91 (120 mmol scale): 
 
 
 To a 1-liter, flame-dried flask equipped with a large magnetic stirbar was added 
solid KHMDS (95% KHMDS, 63.0 g, 300 mmol, 2.5 equiv) in a nitrogen-filled 
glovebox. The flask was capped with a rubber septum, removed from the glovebox, and 
anhydrous THF (300 mL) was charged to the flask and the resulting mixture stirred at 22 
°C for 10 minutes to ensure complete dissolution of the solid. The resulting solution was 
then cooled to –78 °C in a dry ice/acetone bath (Note: Adequate cooling of the reaction 
mixture is critical for this reaction. A large capacity Pope brand cryogenic dewar was 
utilized for this procedure). After stirring for 20 minutes at –78 °C, a solution of (S)-
pulegone (18.3 g, 120 mmol, 1.0 equiv) in THF (50 mL) was added dropwise by cannula 
transfer over 30 minutes, resulting in a homogenous yellow solution that was stirred for 
an additional 20 minutes. A solution of rac-3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine 
(72.1 g, 276 mmol, 2.3 equiv) in THF (400 mL) was then added dropwise by cannula 
transfer over the course of 1 h, producing a deep orange-red solution that was stirred for 
an additional 15 minutes. The reaction was then quenched by the addition of sat. aq. NH-
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4Cl solution (250 mL) and the cold bath replaced with a water bath at ambient 
temperature. Once the temperature of the mixture had reached 23 °C, the biphasic 
mixture was then stirred rapidly for 1 h to allow for hydrolysis of the imine byproduct (N-
benzylidenebenzenesulfonamide). The mixture was subsequently poured into a 
separatory funnel, diluted with EtOAc (500 mL), and washed with sat. aq. NH4Cl (3 x 
250 mL). The combined aqueous washings were then extracted with EtOAc (2 x 300 
mL), and the combined organic layers washed with brine (500 mL), dried over anhydrous 
MgSO4, filtered, and concentrated in vacuo. The resulting thick slurry was then 
redissolved in EtOAc (100 mL) and treated with hexanes (400 mL), resulting in the 
precipitation of benzenesulfonamide, and the solids removed by filtration over Celite, 
rinsing with 4:1 hexanes/EtOAc (200 mL) to fully elute off the products. Concentration 
in vacuo affords an orange oil. Repeated purification by silica gel chromatography (500 g 
wet silica, 20 to 30 to 40% EtOAc in hexanes) affords a thick, slightly yellow oil that was 
determined to be 97% pure by 1H NMR (9.19 g, 49.9 mmol, 42% yield).  
 
Notes: Residual imine byproduct, N-benzylidenebenzenesulfonamide, has a slightly 
higher Rf than the product that can be challenging to remove by chromatography. In cases 
where the imine is not fully hydrolyzed, the product can be redissolved in EtOAc (200 
mL) and stirred with sat. aq. NH4Cl (200 mL) for 12 h. The resulting benzaldehyde and 
benzenesulfonamide products are then readily removed by silica gel chromatography. A 
sample was further purified by silica gel chromatography for characterization purposes.  
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TLC (40% EtOAc/Hexanes), Rf: 0.43 (p-anisaldehyde); 1H NMR (CDCl3, 500 MHz): 
δ 5.06 (m, 2H), 4.34 (dd, J = 10.9, 4.7 Hz, 1H), 3.37 (d, J = 4.7 Hz, 1H), 2.48 (s, 1H), 
2.03 – 1.82 (m, 3H), 1.81 (app. s, 3H), 1.68 – 1.52 (m, 2H), 1.19 (d, J = 6.3 Hz, 3H); 13C 
NMR (CDCl3, 126 MHz): δ 209.7, 145.4, 112.5, 80.1, 77.8, 43.6, 37.1, 26.7, 19.7, 19.0; 
FTIR (NaCl, thin film): 3421, 2955, 2929, 1720, 1456, 1376 cm-1; LRMS: calc’d for 
[M+H]+: 185.1, found: 185.1; [α]D25: –38 (c = 1.0 CHCl3). 
 
Preparation of Ketone 92: 
 
 To a 500-mL, flame-dried flask was added diol 10 (9.14 g, 49.6 mmol, 1.0 equiv), 
tetrabutylammonium iodide (36.6 g, 99.2 mmol, 2.0 equiv), and anhydrous CH2Cl2 (200 
mL). The solution was cooled to 0 °C in an ice/water bath and iPr2NEt (69 mL, 400 
mmol, 8.0 equiv) was added rapidly via syringe. After 10 minutes, chloromethyl benzyl 
ether (34.4 mL, 248 mmol, 5.0 equiv) was added dropwise via syringe. The cold bath was 
subsequently removed and the solution was allowed to warm to 20 °C over 45 minutes. 
The flask was equipped with an oven-dried reflux condenser and then submerged into a 
preheated oil bath at 55 °C (internal temp. 50 °C), resulting in gentle reflux of the pale 
yellow solution. As the reaction proceeds, the color of the solution changes to a deep red. 
After 40 h, the solution was cooled to ambient temperature, poured into a 1-liter 
separatory funnel, diluted with additional CH2Cl2 (250 mL), and washed sequentially 
with sat. aq. NaHCO3 (250 mL) and sat. aq. NH4Cl (3 x 200 mL). The combined aqueous 
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washings were then extracted with CH2Cl2 (2 x 100 mL), then the combined organic 
layers were washed with 0.2 N NaOH (300 mL) and brine (300 mL), dried over 
anhydrous MgSO4, filtered, and concentrated in vacuo to afford a thick red slurry. EtOAc 
(100 mL) was added and the suspension vigorously agitated to ensure suspension of the 
solids. The suspension was then treated with hexanes (400 mL) resulting in the additional 
precipitation of ammonium salts, and the solids removed via filtration over Celite, rinsing 
with hexanes/EtOAc (4:1, 200 mL). Concentration in vacuo resulted in isolation of a 
homogeneous red oil. Purification by silica gel chromatography (7 to 9 to 12% EtOAc in 
hexanes) afforded ketone 92 as a thick, colorless oil (13.6 g, 32.1 mmol, 65% yield).  
 
Notes: A similar yield was obtained albeit at longer reaction times in the absence of Bu-
4NI. 
 
TLC (10% EtOAc/Hexanes), Rf: 0.23 (UV, p-anisaldehyde). 1H NMR (500 MHz, 
CDCl3): δ 7.38 – 7.26 (m, 10H), 5.20 (app. p, J = 1.4 Hz, 1H), 5.05 (app. t, J = 1.0 Hz, 
1H), 4.84 (d, J = 7.1 Hz, 1H), 4.80 (d, J = 11.9 Hz, 1H), 4.78 (d, J = 7.1 Hz, 1H), 4.78 (d, 
J = 7.1 Hz, 1H), 4.74 (d, J = 11.7 Hz, 1H), 4.72 (d, J = 7.1 Hz, 1H), 4.66 (d, J = 11.7 Hz, 
1H), 4.65 (d, J = 10.9 Hz, 1H), 4.64 (d, J = 11.9 Hz, 1H), 2.29 (dt, J = 14.4, 2.9 Hz, 1H), 
1.96 – 1.77 (m, 3H), 1.74 – 1.67 (m, 1H), 1.71 (app. q, J = 0.7 Hz, 3H), 1.20 (d, J = 6.1 
Hz, 3H). 13C NMR (126 MHz, CDCl3): δ 142.8, 137.8, 137.5, 128.5, 128.5, 128.4, 
127.9, 127.8, 127.8, 127.6, 116.4, 94.3, 90.4, 87.8, 83.0, 71.1, 69.9, 41.8, 34.2, 27.6, 19.7, 
19.5. FTIR (NaCl, thin film): 2890, 1734, 1454, 1379, 1157, 1057, 1015 cm-1; HRMS: 
calc’d for [M+Na]+: 447.2142, found: 447.2126. [α]D25: +58 (c = 1.0, CHCl3). 
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Preparation of Enyne 93: 
 
 To a 1-liter, flame-dried round-bottomed flask was charged ketone 11 (13.3 g, 
31.3 mmol, 1.0 equiv) and THF (310 mL). The solution was placed in an ice/water bath 
at 0 °C and stirred for 25 minutes for adequate cooling, then a solution of 
propynylmagnesium bromide (0.5 M solution, 125 mL, 62.5 mmol, 2.0 equiv) was added 
dropwise by cannula transfer over 45 min. The reaction was stirred for an additional 30 
min and then carefully quenched by the addition of sat. aq. NH4Cl (300 mL). The mixture 
was diluted with Et2O (300 mL) and washed with sat. aq. NH4Cl (2 x 100 mL), then the 
combined aqueous layers extracted with Et2O (200 mL). The combined organic layers 
were then washed with brine (300 mL), dried over anhydrous MgSO4, filtered, and 
concentrated in vacuo to afford a thick, light yellow oil. 1H NMR analysis of the crude 
product indicated that the reaction occurs with complete consumption of starting material 
in a 5:1 diastereomeric ratio. Purification by silica gel chromatography (15 to 20 EtOAc 
in hexanes) afforded enyne 93 as a viscous oil that slowly solidifies into colorless, 
semicrystalline needles (11.8 g, 25.4 mmol, 81% yield) in addition to minor diastereomer 
SI-1 (1.75 g, 3.76 mmol, 12% yield). 
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Major Diastereomer (93): 
TLC (20% EtOAc/Hexanes), Rf: 0.38 (p-anisaldehyde); 1H NMR (500 MHz, CDCl3):  
δ 7.40 – 7.33 (m, 8H), 7.32 – 7.27 (m, 2H), 5.24 (p, J = 1.5 Hz, 1H), 5.20 (d, J = 6.9 Hz, 
1H), 5.20 (dd, J = 1.8, 0.8 Hz, 1H), 4.96 (d, J = 6.8 Hz, 1H), 4.89 (d, J = 12.0 Hz, 1H), 
4.82 (d, J = 11.8 Hz, 1H), 4.77 (d, J = 6.8 Hz, 1H), 4.74 (d, J = 6.8 Hz, 1H), 4.63 (d, J = 
12.0 Hz, 1H), 4.58 (d, J = 11.8 Hz, 1H), 3.64 (d, J = 10.6 Hz, 1H), 2.72 (s, 1H), 2.17 – 
2.08 (m, 1H), 1.96 – 1.92 (m, 3H), 1.90 – 1.78 (m, 1H), 1.81 (s, 3H), 1.74 (dt, J = 14.4, 
3.1 Hz, 1H), 1.55 – 1.48 (m, 2H), 1.09 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, 
CDCl3): δ 144.7, 138.0, 137.9, 128.4, 128.4, 127.8, 127.7, 127.6, 117.0, 96.7, 90.3, 86.4, 
85.3, 82.0, 80.9, 75.3, 70.7, 70.5, 31.8, 27.6, 27.1, 22.0, 19.0, 3.8; FTIR (NaCl, thin 
film): 3401, 2952, 2927, 2240, 1497, 1453, 1379, 1022 cm-1; HRMS: calc’d for 
[M+Na]+: 487.2445, found: 487.2438; [α]D25: +84 (c = 1.1, CHCl3). 
 
Minor Diastereomer (SI-1): 
TLC (20% EtOAc/Hexanes), Rf: 0.31 (p-anisaldehyde); 1H NMR (500 MHz, CDCl3):  
δ 7.39 – 7.31 (m, 8H), 7.31 – 7.26 (m, 2H), 5.24 (p, J = 1.4 Hz, 1H), 5.16 (dd, J = 1.6, 0.8 
Hz, 1H), 5.10 (d, J = 7.0 Hz, 1H), 4.86 (d, J = 7.0 Hz, 1H), 4.85 (d, J = 12.0 Hz, 1H), 
4.81 (d, J = 11.8 Hz, 1H), 4.81 (d, J = 7.2 Hz, 1H), 4.77 (d, J = 7.2 Hz, 1H), 4.70 (d, J = 
12.0 Hz, 1H), 4.55 (d, J = 11.9 Hz, 1H), 4.05 (s, 1H), 3.58 (d, J = 10.5 Hz, 1H), 2.19 – 
2.11 (m, 1H), 1.96 (q, J = 0.7 Hz, 3H), 1.95 – 1.87 (m, 2H), 1.87 (s, 3H), 1.59 – 1.54 (m, 
2H), 1.06 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 144.5, 137.8, 137.5, 
128.4, 128.4, 127.8, 127.8, 127.7, 127.7, 117.5, 97.0, 91.1, 89.2, 86.4, 83.2, 78.3, 77.5, 
71.1, 70.2, 35.3, 29.9, 27.9, 22.4, 18.6, 3.9; FTIR (NaCl, thin film): 2952, 2927, 2240, 
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1454, 1380, 1023 cm-1; HRMS: calc’d for [M+Na]+: 487.2445, found: 487.2456; [α]D25: 
+61 (c = 0.90, CHCl3). 
 
Preparation of Methyl Ketone 94: 
 
 To a 1-liter, round-bottomed flask was charged enyne 93 (11.7 g, 25.2 mmol, 1.0 
equiv), followed by CH2Cl2 (400 mL) and MeOH (100 mL). The solution was purged 
with O2 by means of a gas dispersion tube while cooling to –78 °C in a dry ice/acetone 
bath. A mixture of O3/O2 [Caution! Ozone is an extremely hazardous chemical! Proper 
training and use in a well-ventilated fume hood are necessary] was then passed through 
the solution and the reaction carefully monitored by TLC to track disappearance of the 
starting material. After 4.5 h, the solution slowly changed from a colorless solution to a 
very slight, pale blue color. O2 (g) was sparged through the solution at an increased rate 
to purge out excess ozone, followed by N2 (g) for 10 minutes. Triphenylphosphine (6.61 
g, 25.2 mmol, 1.0 equiv) was then added in a single portion to the mixture at –78 °C. The 
mixture was allowed to warm to 23 °C with efficient stirring under N2 over the course of 
1 h, then concentrated in vacuo to afford a thick oil. Purification by silica gel 
chromatography (20 to 30 to 35% EtOAc in hexanes, sample loaded in 10 mL of CH2Cl2) 
afforded methyl ketone 94 as a white amorphous solid (10.6 g, 22.7 mmol, 90% yield).  
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Notes: The product readily precipitates from hexanes/EtOAc solutions. To ensure 
quantitative transfer and prevent streaking, complete dissolution in CH2Cl2 (10 mL) is 
necessary for loading the silica gel column. Furthermore, although triphenylphosphine 
oxide could be removed by careful trituration from the reaction mixture, purification in 
this manner was undesirable due to the risk of product loss.  
 
TLC (40% EtOAc/Hexanes), Rf: 0.50 (UV, p-anisaldehyde); 1H NMR (500 MHz, 
CDCl3):  δ 7.38 – 7.33 (m, 8H), 7.33 – 7.27 (m, 2H), 5.17 (d, J = 7.0 Hz, 1H), 4.93 (d, J 
= 7.0 Hz, 1H), 4.89 (d, J = 6.8 Hz, 1H), 4.88 (d, J = 11.9 Hz, 1H), 4.77 (d, J = 11.9 Hz, 
1H), 4.76 (d, J = 6.8 Hz, 1H), 4.64 (d, J = 11.9 Hz, 1H), 4.62 (d, J = 11.9 Hz, 1H), 3.57 
(d, J = 10.6 Hz, 1H), 3.08 (s, 1H), 2.40 (s, 3H), 2.26 (ddd, J = 15.0, 13.8, 4.3 Hz, 1H), 
1.96 – 1.85 (m, 1H), 1.83 (s, 3H), 1.77 (dt, J = 15.0, 3.2 Hz, 1H), 1.57 (dtd, J = 13.6, 4.3, 
2.9 Hz, 1H), 1.36 (tdd, J = 13.7, 12.5, 3.5 Hz, 1H), 1.06 (d, J = 6.5 Hz, 3H); 13C NMR 
(126 MHz, CDCl3): δ 209.4, 137.8, 137.4, 128.4, 128.4, 127.8, 127.7, 127.7, 127.7, 96.5, 
91.1, 88.1, 85.7, 82.9, 80.1, 72.5, 70.8, 70.6, 31.5, 28.1, 27.1, 24.6, 18.7, 3.8; FTIR 
(NaCl, thin film): 3402, 2951, 2927, 2235, 1713, 1453, 1020 cm-1; HRMS: calc’d for 
[M+Na]+: 489.2248, found: 489.2246; [α]D25: +97 (c = 1.0, CHCl3). 
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Preparation of Diyne 98: 
 
 To a 1-liter, oven-dried, round-bottomed flask was added ethylmagnesium 
bromide (1.0 M in THF, 114 mL, 114 mmol, 5.0 equiv) and THF (114 mL). The solution 
was cooled to 0 °C in an ice/water bath and ethoxyacetylene (50 wt % in hexanes, 23.8 
mL, 6.0 equiv) added dropwise by syringe. The resulting brown solution was stirred at 0 
°C for 15 minutes, then removed from the ice bath and allowed to warm to room 
temperature over 30 minutes. The dark brown solution was then recooled to 0 °C in an 
ice/water bath, and a solution of ketone 94 (10.6 g, 22.7 mmol, 1.0 equiv) in THF (100 
mL) was added via cannula transfer over 30 minutes. Upon completion of the addition, 
the dark brown solution was stirred for an additional 20 minutes, then quenched by the 
addition of sat. aq. NH4Cl (300 mL), diluted with EtOAc (300 mL), and washed with 
additional sat. aq. NH4Cl (2 x 200 mL). The combined organic layers were extracted with 
additional EtOAc (250 mL), and the combined organic layers were washed with brine 
(300 mL), dried over anhydrous MgSO4, filtered, and concentrated in vacuo. 1H NMR 
analysis of the mixture reveals approximately 85% conversion. Purification of the 
resulting brown oil, twice, by silica gel chromatography (30 to 35% EtOAc in hexanes) 
afforded diyne 97 (9.13 g, 17.0 mmol, 75% yield) as a light yellow oil that very slowly 
solidified to a slightly yellow amorphous solid under high vacuum, along with a mixture 
OH
O
O
Me
O
Me
Me
(75% yield)
94
BnO
BnO
O
O
Me
O
Me
Me
97
BnO
BnO
OH
H
OEt
*
*stereochemistry unassigned
EtO MgBr
THF, 0 °C
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of recovered starting material and product (2.2 g) that could be resubjected for further 
material throughput. 
 
Notes: Incomplete conversion is typically observed. Removal of starting material can be 
challenging on larger scale. 1,2-Addition into the methyl ketone appears to occur with 
complete diastereoselectivity, although the absolute configuration at the newly formed 
(albeit inconsequential given the subsequent step) stereocenter could not be 
unambiguously assigned via 2D-NMR spectroscopic techniques.  
 
TLC (40% EtOAc/Hexanes), Rf: 0.40 (UV, p-anisaldehyde); 1H NMR (500 MHz, 
CDCl3):  δ 7.40 – 7.27 (m, 10H), 5.13 (d, J = 6.9 Hz, 1H), 5.11 (d, J = 6.8 Hz, 1H), 4.99 
(d, J = 6.8 Hz, 1H), 4.95 (d, J = 6.9 Hz, 1H), 4.88 (d, J = 11.9 Hz, 1H), 4.81 (d, J = 11.7 
Hz, 1H), 4.74 (d, J = 11.6 Hz, 1H), 4.60 (d, J = 11.9 Hz, 1H), 4.50 (s, 1H), 4.03 (q, J = 
7.1 Hz, 2H), 3.70 (s, 1H), 3.56 (d, J = 10.6 Hz, 1H), 2.27 (dt, J = 15.6, 3.4 Hz, 1H), 2.12 
(ddd, J = 15.4, 13.8, 4.3 Hz, 1H), 1.88 – 1.81 (m, 1H), 1.84 (s, 3H), 1.80 (s, 3H), 1.55 
(dq, J = 11.8, 4.1 Hz, 1H), 1.35 – 1.25 (m, 1H), 1.31 (t, J = 7.1 Hz, 3H), 1.03 (d, J = 6.5 
Hz, 3H); 13C NMR (126 MHz, CDCl3): 137.9, 137.7, 128.4, 128.3, 128.0, 127.7, 127.6, 
127.6, 97.0, 94.4, 89.2, 87.5, 84.1, 83.3, 81.7, 75.4, 74.8, 74.2, 70.6, 70.2, 42.5, 31.6, 
28.9, 27.0, 22.8, 18.7, 14.5, 3.9.; FTIR (NaCl, thin film): 3402, 2983, 2929, 2262, 1457, 
1022 cm-1; HRMS: calc’d for [M+Na]+: 559.2666, found: 559.2662; [α]D25: +11 (c = 1.1, 
CHCl3). 
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Preparation of Lactone 96: 
 
To a 200 mL, round-bottomed flask was added diyne 97 (8.97 g, 16.7 mmol, 1.0 
equiv) and anhydrous PhMe (84 mL). The solution was stirred vigorously at 23 °C for 15 
minutes to ensure complete dissolution of the starting material, then the flask was 
submerged in an ice/water bath and allowed to cool over 15 minutes. AgOTf (85.6 mg, 
0.334 mmol, 0.02 equiv) was weighed into a 1-dram vial in a nitrogen-filled glovebox 
and then added directly to the solution against a positive pressure of Argon, and the 
resulting mixture stirred vigorously at 0 °C for 20 min. The entire cold solution was then 
directly and rapidly loaded onto a silica gel column pre-equilibrated with 20% EtOAc in 
hexanes, and the compound purified by silica gel chromatography (20 to 30 to 40% 
EtOAc in hexanes) to provide lactone 96 as a pale yellow oil (7.38 g, 15.0 mmol, 90% 
yield).    
 
Notes: The reaction is challenging to monitor by TLC since the product and starting 
material have nearly identical Rf’s. Since the reaction is purified directly by 
chromatography on scale, it is recommended that preparation of the silica gel column is 
performed prior to the addition of AgOTf so that the reaction can be immediately 
purified. Prolonged reaction times (>1 h) can result in the acid-catalyzed, hydrolytic 
cleavage of the benzyloxymethyl groups. 
(90% yield)
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TLC (40% EtOAc/Hexanes), Rf: 0.40 (UV, p-anisaldehyde); 1H NMR (500 MHz, 
CDCl3): δ 7.39 – 7.27 (m, 10H), 5.85 (q, J = 1.5 Hz, 1H), 5.12 (d, J = 7.3 Hz, 1H), 5.08 
(d, J = 6.6 Hz, 1H), 5.06 (d, J = 6.6 Hz, 1H), 4.91 (d, J = 7.3 Hz, 1H), 4.84 (d, J = 11.9 
Hz, 1H), 4.76 (d, J = 11.7 Hz, 1H), 4.65 (d, J = 11.7 Hz, 1H), 4.59 (d, J = 12.0 Hz, 1H), 
3.70 (d, J = 10.1 Hz, 1H), 2.07 (tdd, J = 9.3, 6.7, 4.6 Hz, 1H), 2.01 (d, J = 1.5 Hz, 3H), 
2.02 – 1.96 (m, 1H), 1.77 (s, 3H), 1.71 – 1.47 (m, 3H), 1.12 (d, J = 6.6 Hz, 3H); 13C 
NMR (126 MHz, CDCl3): δ 162.5, 138.1, 137.4, 128.5, 128.4, 127.9, 127.8, 127.7, 
127.5, 118.6, 96.8, 91.5, 85.2, 83.8, 81.4, 80.6, 76.6, 70.6, 70.5, 32.4, 32.3, 27.2, 18.5, 
17.9, 3.8; FTIR (NaCl, thin film): 2954, 2927, 2245, 1727, 1247, 1167, 1025 cm-1; 
HRMS: calc’d for [M+Na]+: 513.2248, found: 513.2236;[α]D25: +34 (c = 0.50, CHCl3). 
 
Preparation of Enyne 98: 
 
 
 To a flame-dried, 1-liter, round-bottomed flask was charged CuI (8.46 g, 44.4 
mmol, 3.0 equiv) and THF (400 mL). The suspension was cooled to –78 °C in a dry 
ice/acetone bath and vinylmagnesium bromide (1 M in THF, 89 mL, 89 mmol, 6.0 equiv) 
was added dropwise by syringe. Upon completion of the addition, the mixture was stirred 
for an additional 15 minutes, then a solution of lactone 96 (7.26 g, 14.8 mmol, 1.0 equiv) 
in THF (100 mL) was added dropwise by cannula transfer. The resulting mixture was 
O
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O
Me
Me
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MgBr O
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O
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Me
O
H
CuI (3.0 equiv)
THF, –78 to – 30 °C
(84% yield)
(6.0 equiv)
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maintained at –78 °C for 15 minutes, then the mixture was gradually warmed to –30 °C 
over 30 minutes, and stirring maintained at –30 °C for 30 minutes. The reaction was then 
carefully quenched by the addition of sat. aq. NH4Cl (300 mL) and warmed to ambient 
temperature. The reaction was then diluted with Et2O (400 mL) and the biphasic mixture 
filtered through a short pad of Celite to remove precipitated red copper solids. The 
resulting mixture was then poured into a separatory funnel and washed with sat. aq. NH-
4Cl (2 x 200 mL), and the combined aqueous layers extracted with additional Et2O (2 x 
200 mL). The combined organic layers were then washed with brine (400 mL), dried over 
anhydrous MgSO4 and filtered over a short pad of silica gel to remove additional red 
copper-based precipitates, and the resultant solution concentrated in vacuo to afford a 
colorless oil. Purification of the crude residue by silica gel chromatography (20 to 30% 
EtOAc in hexanes) afforded enyne 98 as a slightly yellow oil (6.45 g, 12.4 mmol, 84% 
yield). 
 
TLC (40% EtOAc/Hexanes), Rf: 0.53 (UV, p-anisaldehyde); 1H NMR (500 MHz, 
CDCl3): δ 7.39 – 7.27 (m, 10H), 6.81 (dd, J = 17.7, 10.8 Hz, 1H), 5.16 (d, J = 7.2 Hz, 
1H), 5.09 (dd, J = 4.0, 0.8 Hz, 1H), 5.08 – 5.05 (m, 1H), 4.99 (d, J = 7.2 Hz, 1H), 4.89 (d, 
J = 11.9 Hz, 1H), 4.82 (d, J = 7.1 Hz, 1H), 4.77 (d, J = 11.7 Hz, 1H), 4.71 (d, J = 7.1 Hz, 
1H), 4.60 (d, J = 11.9 Hz, 1H), 4.51 (d, J = 11.8 Hz, 1H), 3.66 (d, J = 10.7 Hz, 1H), 3.49 
(d, J = 15.6 Hz, 1H), 2.13 (d, J = 15.6 Hz, 1H), 2.07 – 1.94 (m, 2H), 1.91 (s, 3H), 1.56 – 
1.46 (m, 3H), 1.26 (s, 3H), 1.08 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 
170.6, 144.9, 138.0, 137.4, 128.4, 128.4, 127.8, 127.8, 127.8, 127.6, 111.6, 97.6, 90.5, 
86.0, 85.8, 83.3, 81.3, 77.2, 71.0, 70.5, 44.2, 43.7, 31.0, 27.4, 26.7, 24.1, 18.8, 3.9; FTIR 
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(NaCl, thin film): 2954, 2928, 2871, 1752, 1454, 1237, 1026 cm-1; HRMS: calc’d for 
[M+Na]+: 541.2561, found: 541.2539; [α]D25: +76 (c = 1.0, CHCl3). 
 
Evaluation of Pauson–Khand Reaction Conditions 
Evaluation of Pauson–Khand reaction conditions were performed with enyne 14 
on 0.20 mmol scale (104 mg). A variety of conditions employing cobalt,17,34 
molybdenum,18,35 and rhodium19 complexes were surveyed following literature precedent. 
Isolated yields are indicated for the combined mixture of diastereomers, and were 
obtained after purification by silica gel chromatography. In entries 1 and 2 (cobalt-
mediated), the diastereomeric ratios were obtained by 1H NMR after silica gel 
purification due to the presence of paramagnetic Co-species, whereas in the remainder of 
the entries, diastereomeric ratios were obtained by 1H NMR of the crude reaction 
mixtures. 
 
Table S1. Evaluation of Pauson–Khand Reaction Conditions 
 
 
O
O
Me
O
Me
Me
O
H O
Me
O
Me
O
MeO
H
Oconditions
O
Me
O
Me
O
O H
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BnO BnO BnO
BnOBnO BnO
98 99a 99b
dr Yield 15Conditions
Co2(CO)8 (1.2 equiv), THF, 12 h; then DMSO, 65 °C
Co2(CO)8 (1.2 equiv), CH2Cl2, 9 h; then NMO, 23 °C
Mo(CO)6 (1.2 equiv), DMSO, PhMe, 110 °C
Mo(CO)3(DMF)3 (1.1 equiv), CH2Cl2, 23 °C
[RhCl(CO)2]2 (1 mol %), CO (1 atm), m-xylene, 110 °C
1.
2.
3.
4.
5.
2.2 :1
4.5 :1
--
>20:1
>20:1
46% 
78%
trace
67% 
85%
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  A sample of the minor diastereomer (99b) was obtained via purification of entry 2 for 
characterization purposes. 
 
Minor Diastereomer (99b): 
TLC (70% EtOAc/Hexanes), Rf: 0.52 (UV, p-anisaldehyde). 1H NMR (500 MHz, 
CDCl3):  δ 7.38 – 7.26 (m, 8H), 7.25 – 7.20 (m, 2H), 5.24 (d, J = 5.9 Hz, 1H), 5.06 (d, J 
= 6.0 Hz, 1H), 4.83 (d, J = 6.8 Hz, 1H), 4.77 (d, J = 11.8 Hz, 1H), 4.70 (d, J = 6.8 Hz, 
1H), 4.64 (d, J = 11.8 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.41 (d, J = 11.5 Hz, 1H), 4.02 
(d, J = 11.0 Hz, 1H), 2.83 (ddt, J = 7.4, 5.0, 2.5 Hz, 1H), 2.69 (dd, J = 18.6, 1.0 Hz, 1H), 
2.65 (dd, J = 16.4, 6.7 Hz, 1H), 2.63 (d, J = 18.7 Hz, 1H), 2.35 – 2.23 (m, 1H), 2.33 (dd, 
J = 16.4, 5.1 Hz, 1H), 2.08 (d, J = 2.4 Hz, 3H), 2.02 – 1.91 (m, 1H), 1.79 – 1.64 (m, 2H), 
1.63 – 1.52 (m, 1H), 1.19 (d, J = 6.5 Hz, 3H), 1.11 (s, 3H); 13C NMR (126 MHz, 
CDCl3): δ 208.8, 172.3, 168.0, 137.9, 136.4, 135.9, 128.6, 128.3, 128.2, 128.1, 127.7, 
127.6, 91.8, 90.6, 89.3, 89.0, 78.2, 70.5, 70.5, 51.1, 48.0, 42.8, 41.8, 30.0, 28.7, 21.9, 
18.5, 16.7, 9.4; FTIR (NaCl, thin film): 2929, 1748, 1707, 1453, 1234, 1025, 1008 cm-1; 
HRMS: calc’d for [M+Na]+: 569.2510, found: 569.2510; [α]D25: –140 (c = 0.20, CHCl3). 
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Preparation of Enone 15: 
 
 To a 500-mL, round-bottomed flask containing enyne 98 (6.33 g, 12.2 mmol, 1.0 
equiv) was added [RhCl(CO)2]2 (47.4 mg, 0.122 mmol, 0.01 equiv) in a nitrogen-filled 
glovebox. The flask was capped with a rubber septum, removed from the glovebox, and 
anhydrous m-xylene (120 mL) was added via syringe. The flask was equipped with an 
outlet needle and dry argon was bubbled through the solution for five minutes, followed 
by carbon monoxide for five minutes [Caution! Carbon monoxide is highly toxic. This 
reaction must be run in an efficient fume hood!]. The vent needle was removed and a CO 
atmosphere was maintained in the flask by means of a double-walled balloon, then the 
flask was submerged into a preheated oil bath at 110 °C. After heating for 2 h, the 
reaction was cooled to ambient temperature, sparged with N2 to thoroughly expel excess 
CO gas, then the solvent was removed in vacuo (an efficient rotovap was utilized with a 
bath temperature at 50 °C) to afford a thick, dark orange oil. 1H NMR analysis of the 
unpurified reaction mixture could not identify traces of the undesired diastereomer, 99b. 
Purification by silica gel chromatography (30 to 50 to 70 % EtOAc in hexanes) afforded 
enone 99a as a crunchy foam. Dissolution of the resulting foam in Et2O followed by 
reevaporation (2 x 100 mL) affords enone 99a as an off-white powder (5.66 g, 10.4 
O
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mmol, 85% yield). Single crystals suitable for X-ray diffraction were obtained from this 
material by crystallization from Et2O (See S30 for Data). 
 
TLC (70% EtOAc/Hexanes), Rf: 0.60 (UV, p-anisaldehyde); 1H NMR (500 MHz, 
CDCl3):  δ 7.37 – 7.27 (m, 10H), 5.02 (d, J = 6.9 Hz, 1H), 4.98 (d, J = 6.9 Hz, 1H), 4.85 
(d, J = 11.9 Hz, 1H), 4.85 (d, J = 6.7 Hz, 1H), 4.78 (d, J = 6.8 Hz, 1H), 4.70 (d, J = 11.7 
Hz, 1H), 4.63 (d, J = 11.7 Hz, 1H), 4.59 (d, J = 11.9 Hz, 1H), 4.13 (d, J = 10.4 Hz, 1H), 
3.63 (dtd, J = 8.7, 3.4, 1.7 Hz, 1H), 2.48 (dd, J = 18.4, 6.6 Hz, 1H), 2.32 (dd, J = 19.5, 1.3 
Hz, 1H), 2.28 – 2.21 (m, 1H), 2.25 (d, J = 19.6 Hz, 1H), 2.06 (dd, J = 18.4, 3.3 Hz, 1H),  
2.03 – 1.96 (m, 1H), 1.93 (d, J = 2.7 Hz, 3H), 1.75 (dtd, J = 11.5, 4.3, 2.6 Hz, 1H), 1.71 – 
1.57 (m, 2H), 1.16 (d, J = 6.6 Hz, 3H), 1.14 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 
209.2, 174.1, 168.8, 140.9, 137.6, 137.0, 128.5, 128.4, 128.0, 127.9, 127.7, 127.6, 95.5, 
90.1, 89.3, 87.1, 79.2, 71.2, 70.7, 51.0, 45.4, 37.3, 35.6, 32.1, 28.5, 20.6, 18.8, 18.2, 10.1; 
FTIR (NaCl, thin film): 2954, 2872, 1748, 1707, 1454, 1209, 1154, 1042, 1025 cm-1; 
HRMS: calc’d for [M+Na]+: 569.2510, found: 569.2523; [α]D25: +180 (c = 1.0, CHCl3). 
Preparation of Diosphenol 102: 
 
 
 To a 2-dram vial was added enone 99a (109.0 mg, 0.200 mmol, 1.0 equiv), SeO2 
(222 mg, 20.0 mmol, 10 equiv), dioxane (4.0 mL), and H2O (36 µL, 2.00 mmol, 10 
equiv). The vial was sealed with a Teflon cap, then submerged in an oil bath preheated to 
O
Me
O
Me
O
MeO
H
O
O
HO
Me
O
Me
O
O
H
Me
O
OHSeO2
BnO BnO
BnOBnO
H2O (10 equiv)
1,4-dioxane, 110 °C
99a 102
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110 °C for 1 h. The vial was then cooled to ambient temperature, diluted with EtOAc (50 
mL) and washed with sat. aq. NaHCO3 (2 x 50 mL). The combined aqueous layers were 
then extracted with EtOAc (15 mL), the combined organics dried over anhydrous 
Na2SO4, and the solution filtered and concentrated in vacuo to afford a dark orange foam. 
Purification by silica gel chromatography (2% MeOH in CH2Cl2) affords an orange foam 
that was used in the subsequent reaction without additional purification.  
 
Notes: Large amounts of Se-based byproducts (both selenium black and selenium red) 
are produced during the course of this reaction. Although material post-chromatography 
appears to be spectroscopically pure by 1H NMR spectroscopy, integration of purified 
material against an internal standard indicates that a significant amount of selenium red 
(colloidal) is co-eluted during silica gel chromatography, and thus a two-step yield is 
obtained after triflation (see next step). 
 
A sample of diosphenol 102 was futher purified by repeated chromatography to remove 
Se-based byproducts to afford an analytically pure sample for characterization purposes, 
affording 102 as a colorless foam. 
 
TLC (70% EtOAc/Hexanes), Rf: 0.50 (UV, KMnO4); 1H NMR (500 MHz, CDCl3):  δ 
7.40 – 7.27 (m, 10H), 5.39 (s, 1H), 5.09 (d, J = 5.4 Hz, 1H), 5.01 (d, J = 6.8 Hz, 1H), 
4.97 (d, J = 6.8 Hz, 1H), 4.84 (d, J = 5.4 Hz, 1H), 4.76 (d, J = 11.7 Hz, 1H), 4.71 (d, J = 
11.7 Hz, 1H), 4.71 (d, J = 12.2 Hz, 1H), 4.64 (d, J = 12.2 Hz, 1H), 4.55 (s, 1H), 3.99 (d, J 
= 10.5 Hz, 1H), 2.92 (s, 1H), 2.29 (dd, J = 19.9, 1.2 Hz, 1H), 2.24 (d, J = 19.9 Hz, 1H), 
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2.11 – 2.03 (m, 1H), 2.10 (s, 3H), 1.96 – 1.88 (m, 1H), 1.69 – 1.47 (m, 3H), 1.28 (s, 3H), 
1.05 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 200.1, 166.9, 150.0, 143.9, 
137.0, 136.9, 128.7, 128.6, 128.2, 128.1, 128.0, 127.7, 97.0, 91.4, 90.6, 89.8, 87.1, 80.0, 
71.1, 70.3, 64.4, 45.1, 39.1, 33.3, 27.9, 21.3, 19.9, 18.5, 11.2; FTIR (NaCl, thin film): 
3350, 2926, 1744, 1707, 1405, 1240, 1157, 1034 cm-1; HRMS: calc’d for [M+NH4]+: 
596.2871, found: 596.2854; [α]D25: +79 (c = 0.55, CHCl3). 
 
Preparation of Triflate 103: 
 
 To a 25-mL, round-bottomed flask was added 102 (material directly isolated from 
the previous reaction) and anhydrous CH2Cl2 (4.0 mL). i-Pr2NEt (0.18 ml) was added and 
then solution cooled to –78 °C in a dry ice/acetone bath. N-(5-chloro-2-
pyridyl)bis(trifluoromethanesulfonimide) (Comins’ reagent, 78.5 mg, 0.20 mmol, 1.0 
equiv) was then added in a single portion and the solution stirred for 5 minutes, then the 
cold bath removed and replaced with an ice/water bath at 0 °C. After 1 h, the solution 
was directly loaded onto a silica gel column (30 to 40% EtOAc in hexanes) to afford 
triflate 103 as a colorless foam (79.4 mg, 0.111 mmol, 56% yield). 
 
TLC (40% EtOAc/Hexanes), Rf: 0.40 (UV, KMnO4); 1H NMR (CDCl3, 400 MHz): δ 
7.41 – 7.29 (m, 11H), 5.33 (s, 1H), 5.05 (d, J = 4.7 Hz, 1H), 4.99 (d, J = 6.8 Hz, 1H), 
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4.95 (d, J = 6.9 Hz, 1H), 4.79 (d, J = 4.8 Hz, 1H), 4.77 (d, J = 11.8 Hz, 1H), 4.71 (d, J = 
11.7 Hz, 1H), 4.64 (s, 2H), 4.01 (d, J = 10.5 Hz, 1H), 3.03 (d, J = 1.5 Hz, 1H), 2.49 (d, J 
= 19.9 Hz, 1H), 2.31 (dd, J = 19.9, 1.5 Hz, 1H), 2.26 (s, 3H), 2.15 – 2.05 (m, 1H), 1.96 – 
1.88 (m, 1H), 1.70 – 1.46 (m, 3H), 1.30 (s, 3H), 1.01 (d, J = 6.5 Hz, 3H); 13C NMR (126 
MHz, CDCl3): δ 195.5, 166.0, 164.0, 144.8, 137.0, 136.1, 128.8, 128.7, 128.4, 128.2, 
128.0, 127.8, 118.3 (q, JC-F = 321 Hz), 96.6, 90.5, 90.5, 89.5, 86.0, 79.5, 70.8, 70.0, 63.6, 
45.7, 38.8, 33.2, 27.8, 21.2, 19.8, 18.2, 12.6; FTIR (NaCl, thin film): 3368, 2930, 2875, 
1756, 1732, 1426, 1216, 1038 cm-1; HRMS: calc’d for [M+NH4]+: 728.2347, found 
728.2359; [α]D25: +83 (c = 1.0 CHCl3). 
 
Preparation of Diosphenol 100: 
 
 To an oven-dried, 48-mL, heavy-walled pressure vessel equipped with a magnetic 
stirbar was charged enone 99a (1.09 g, 2.00 mmol, 1.0 equiv), anhydrous SeO2 (2.22 g, 
20.0 mmol, 10.0 equiv), and freshly activated 4Å molecular sieves (prepared via vigorous 
flame-drying at <200 mTorr for 10 minutes, 2.18 g, 200 wt % relative to substrate) in a 
nitrogen-filled glovebox. Anhydrous 1,4-dioxane (20 mL) was then added and the vessel 
was tightly sealed, removed from the glovebox, and submerged in a preheated oil bath at 
110 °C. After 9.0 h, the vessel was allowed to cool to ambient temperature, diluted with 
EtOAc (100 mL), and filtered through a short pad of Celite, rinsing with additional 
EtOAc (50 mL). The resulting filtrate was then washed with sat. aq. NaHCO3 (2 x 50 
SeO2, 4Å MS
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mL), H2O (50 mL), and the combined aqueous layers back extracted with EtOAc (2 x 25 
mL). The combined organics were then dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo to afford an orange foam. 1H NMR analysis of this crude reaction 
mixture, integrating an external standard of phenyltrimethylsilane, indicated that 100 had 
been produced in 34% 1H NMR yield. The crude residue was purified via silica gel 
chromatography (slurry packed column, 2% MeOH in CH2Cl2) to afford a pale orange-
tan foam. The isolated material (typically ~575 mg) was carried to the next reaction 
without further purification.  
 
Notes: It is critical that the reaction is rigorously anhydrous. Strictly anhydrous solvent 
and adequately activated 4Å molecular sieves are necessarily for complete conversion to 
100. Failure to use rigorously anhydrous solvent or adequately flame-dried 4Å molecular 
sieves can result in contaminated material (containing up to ~7% 102), which is 
extremely challenging to separate by silica gel chromatography. Furthermore, failure to 
remove residual 102 from samples carried through the triflation results in an inseparable 
mixture of vinyl triflates 103 and 104.  
 
As above, amounts of Se-based byproducts (both selenium black and selenium red) are 
produced during the course of this reaction. Although material post-chromatography 
appears to be spectroscopically pure by 1H NMR spectroscopy, integration of purified 
material against an internal standard indicates that a significant amount of red selenium 
(colloidal) is co-eluted during silica gel chromatography, and thus a two-step yield is 
obtained after triflation (see next step). 
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A sample of this material was further purified by repeated silica gel chromatography for 
characterization purposes: 
TLC (70% EtOAc/Hexanes), Rf: 0.36 (UV, KMnO4); 1H NMR (500 MHz, CDCl3):  δ 
7.40 – 7.27 (m, 10H), 5.66 (br s, 1H), 5.15 (d, J = 5.7 Hz, 1H), 4.96 (d, J = 6.1 Hz, 1H), 
4.93 (d, J = 6.2 Hz, 1H), 4.89 (d, J = 5.7 Hz, 1H), 4.76 (d, J = 12.1 Hz, 1H), 4.70 (s, 1H), 
4.70 (s, 1H), 4.65 (d, J = 12.1 Hz, 1H), 4.60 (s, 1H), 4.08 (s, 1H), 4.00 (d, J = 10.5 Hz, 
1H), 2.41 (d, J = 19.8 Hz, 1H), 2.25 (d, J = 19.9 Hz, 1H), 2.14 (s, 3H), 2.13 – 2.00 (m, 
1H), 1.92 – 1.81 (m, 1H), 1.64 (dtd, J = 6.7, 4.6, 2.1 Hz, 1H), 1.56 – 1.42 (m, 2H), 1.27 
(s, 3H), 1.08 (d, J = 6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 197.2, 166.7, 149.3, 
146.0, 137.0, 136.4, 128.7, 128.6, 128.4, 128.1, 128.0, 127.8, 97.1, 91.2, 90.6, 90.2, 86.6, 
84.6, 79.9, 71.7, 70.4, 47.3, 40.8, 33.1, 27.9, 21.5, 18.6, 15.1, 11.3; FTIR (NaCl, thin 
film): 3368, 2928, 1747, 1717, 1659, 1454, 1405, 1360, 1155, 1035 cm-1; HRMS: calc’d 
for [M+Na]+: 617.2357, found: 617.2367; [α]D25: +120 (c = 0.86, CHCl3). 
 
Preparation of Vinyl Triflate 104: 
 
 To a 50-mL, round-bottomed flask was added 100 (directly from the previous 
reaction, approximately 575 mg) and anhydrous CH2Cl2 (20 mL). iPr2NEt (0.89 mL) was 
added, and then the solution was cooled to –78 °C in a dry ice/acetone bath. N-(5-chloro-
2-pyridyl) bis(trifluoromethanesulfonimide) (Comins’ reagent, 589 mg, 1.50 mmol) was 
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then added in a single portion and the solution stirred for five minutes, then the cold bath 
removed and replaced with an ice/water bath at 0 °C. After 1 h, the solution was directly 
purified by silica gel chromatography (30 to 40% EtOAc in Hwexanes) to afford triflate 
104 as a slightly off white foam (413 mg, 0.568 mmol, 28% yield, 2 steps). 
TLC(40% EtOAc/Hexanes), Rf: 0.36 (UV, KMnO4); 1H NMR (CDCl3, 400 MHz): δ 
7.41 – 7.28 (m, 10H), 5.09 (d, J = 5.4 Hz, 1H), 4.98 (s, 1H), 4.95 (d, J = 6.2 Hz, 1H), 
4.93 (d, J = 6.2 Hz, 1H), 4.88 (d, J = 5.4 Hz, 1H), 4.73 (d, J = 12.2 Hz, 1H), 4.69 (m, 
2H), 4.65 (d, J = 12.0 Hz, 1H), 4.21 (s, 1H), 3.98 (d, J = 10.5 Hz, 1H), 2.53 (d, J = 20.3 
Hz, 1H), 2.44 (d, J = 20.2 Hz, 1H), 2.30 (s, 3H), 2.08 (tdd, J = 13.8, 7.0, 3.9 Hz, 1H), 
1.93 – 1.83 (m, 1H), 1.70 – 1.60 (m, 1H), 1.54 – 1.44 (m, 2H), 1.28 (s, 3H), 1.07 (d, J = 
6.6 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 192.9, 165.6, 164.6, 144.4, 136.6, 136.2, 
128.8, 128.7, 128.5, 128.2, 128.1, 127.8, 118.3 (q, JC-F = 321 Hz), 96.8, 90.6, 90.4, 90.2, 
85.7, 84.4, 79.5, 71.8, 70.4, 47.6, 40.1, 33.0, 27.8, 21.4, 18.4, 15.1, 12.7; FTIR (NaCl, 
thin film): 3368, 2931, 1743, 1650, 1429, 1243, 1216, 1040 cm-1; HRMS: calc’d for 
[M+NH4]+: 744.2313, found: 744.2296; [α]D25: +58 (c = 0.74, CHCl3). 
 
Preparation of Enone 105: 
 
 In a nitrogen-filled glovebox, an oven-dried, 48-mL capacity heavy-walled 
pressure vessel was charged with vinyl triflate 104 (413 mg, 0.568 mmol, 1.0 equiv), 
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PdCl2(PPh3)2 (159 mg, 0.227 mmol, 40 mol %), anhydrous LiCl (192 mg, 4.54 mmol, 8.0 
equiv), tributyl(2-propenyl)stannane (752 mg, 2.27 mmol, 4.0 equiv), and anhydrous 2-
methyltetrahydrofuran (11 mL). The vial was sealed with a PTFE-lined cap, and 
submerged in a preheated oil bath at 90 °C. After 14 h, the vial was removed from the 
bath and allowed to cool to ambient temperature, then sat. aq. KF (15 mL) was added. 
The solution was stirred for 45 minutes, diluted with EtOAc (50 mL) and washed with 
sat. aq. KF (20 mL). The combined aqueous layers were extracted with additional EtOAc 
(25 mL), and the combined organics washed with brine (50 mL), dried over anhydrous 
Na2SO4, filtered over Celite, and concentrated in vacuo to afford a red-brown oil. 
Purification by silica gel chromatography (30 to 40% EtOAc in hexanes) afforded the 
desired product 105 as an off-white foam (224 mg, 0.363 mmol, 64% yield). 
 
TLC (40% EtOAc/Hexanes), Rf: 0.32 (UV, KMnO4); 1H NMR (CDCl3, 400 MHz): 
7.40 – 7.27 (m, 10H), 5.24 (p, J = 1.6 Hz, 1H), 5.15 (d, J = 5.9 Hz, 1H), 4.96 (d, J = 6.3 
Hz, 1H), 4.94 (d, J = 6.3 Hz, 1H), 4.92 (d, J = 5.9 Hz, 1H), 4.82 (dq, J = 2.0, 1.0 Hz, 1H), 
4.78 (d, J = 12.1 Hz, 1H), 4.70 (s, 2H), 4.64 (d, J = 12.1 Hz, 1H), 4.27 (s, 1H), 4.01 (d, J 
= 10.5 Hz, 1H), 3.94 (s, 1H), 2.42 (d, J = 19.8 Hz, 1H), 2.32 (d, J = 19.8 Hz, 1H), 2.25 (s, 
3H), 2.14 – 2.01 (m, 1H), 1.89 – 1.82 (m, 1H), 1.87 (q, J = 1.5 Hz, 3H), 1.65 (dtt, J = 7.9, 
4.9, 2.2 Hz, 1H), 1.54 – 1.46 (m, 2H), 1.26 (s, 3H), 1.10 (d, J = 6.5 Hz, 3H); 13C NMR 
(126 MHz, CDCl3): δ 202.1, 171.0, 166.8, 143.7, 137.3, 136.5, 135.6, 128.7, 128.5, 
128.4, 128.1, 127.9, 127.7, 118.2, 97.1, 91.3, 91.2, 90.3, 88.1, 85.5, 79.9, 71.8, 70.5, 47.6, 
40.9, 33.1, 27.9, 21.6, 21.4, 18.7, 15.0, 15.0; FTIR (NaCl, thin film): 3412, 2953, 2925, 
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1749, 1709, 1037, 1026 cm-1; HRMS: calc’d for [M+Na]+: 641.2721, found: 641.2729; 
[α]D25: +100 (c = 0.67, CHCl3). 
 
Preparation of 106: 
 
 To an oven-dried, 2-dram vial was added enone 105 (250 mg, 0.404 mmol, 1.00 
equiv), and anhydrous THF (16 mL). The solution was cooled to –15 °C in an ice/MeOH 
bath and solid LiBH4 (132 mg, 6.06 mmol, 15 equiv) was added in a single portion. The 
temperature was carefully maintained between –10 and –15 °C. After 2 h, TLC analysis 
indicated full consumption of the starting material. Sat. aq. NH4Cl was then slowly added 
to the reaction [Caution! Vigorous evolution of H2 gas occurs, particularly in the initial 
stages of addition. Careful, controlled dropwise addition is advised in order to avoid a 
violent reaction]. The mixture was diluted with EtOAc (30 mL), and washed thoroughly 
with sat. aq. NH4Cl (2 x 20 mL), and the combined organic layers extracted with 
additional EtOAc (20 mL). The solution was then concentrated in vacuo, redissolved in 
MeOH (45 mL) and KHF2 (3 M in H2O, 3 mL) was then added and the solution 
vigorously swirled for two minutes and the entire mixture concentrated in vacuo [rotary 
evaporator bath temperature at 35 °C]. The resultant residue was suspended in EtOAc (50 
mL), anhydrous Na2SO4 added, then filtered through a short pad of silica gel to remove 
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salts, and rinsed with additional EtOAc (25 mL), concentrated in vacuo. The resulting 
off-white foam was carried onto the next step without further purification. 
 
A sample of allylic alcohol 106 could be additionally purified by preparative thin-layer 
chromatography (30% EtOAc in CH2Cl2) for characterization purposes. 
 
TLC (40% EtOAc/Hexanes), Rf: 0.12 (UV, KMnO4); 1H NMR (CDCl3, 400 MHz): δ 
7.42 – 7.26 (m, 11H), 5.17 (d, J = 6.5 Hz, 1H), 5.16 – 5.14 (m, 1H), 4.99 (d, J = 5.9 Hz, 
1H), 4.95 (d, J = 5.8 Hz, 1H), 4.87 (d, J = 6.3 Hz, 1H), 4.87 (m, 1H), 4.86 – 4.83 (m, 
1H), 4.79 (d, J = 12.3 Hz, 1H), 4.73 (d, J = 11.8 Hz, 1H), 4.69 (d, J = 11.8 Hz, 1H), 4.61 
(d, J = 12.2 Hz, 1H), 4.41 (s, 1H), 3.91 (d, J = 10.3 Hz, 1H), 3.89 (s, 1H), 3.53 (d, J = 
19.8 Hz, 1H), 2.26 (d, J = 19.8 Hz, 1H), 2.13 – 2.03 (m, 1H), 2.08 (d, J = 4.6 Hz, 1H), 
1.85 (d, J = 2.3 Hz, 3H), 1.85 – 1.83 (m, 3H), 1.79 (ddd, J = 14.9, 4.4, 2.1 Hz, 1H), 1.71 
– 1.63 (m, 1H), 1.60 (s, 3H), 1.56 (ddd, J = 14.9, 12.9, 4.6 Hz, 1H), 1.38 – 1.27 (m, 1H), 
1.30 (s, 3H), 1.09 (d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 168.5, 143.4, 
138.4, 137.7, 136.6, 136.4, 128.7, 128.4, 128.2, 127.7, 127.7, 117.0, 97.3, 91.5, 91.2, 
91.1, 90.4, 88.7, 83.0, 80.6, 72.1, 70.5, 49.2, 39.6, 33.2, 28.3, 21.3, 21.2, 18.9, 16.0, 13.0; 
FTIR (NaCl, thin film): 3453, 2923, 2872, 1742, 1026 cm-1; HRMS: calc’d for 
[M+Na]+: 643.2878, found: 643.2886; [α]D25:  –29 (c = 0.33, CHCl3). 
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Preparation of Anhydroryanodol (3): 
 
 To a 25-mL, round-bottomed flask was charged crude triol 106. Pd(OH)2/C (20 
wt %, 375 mg) was added, followed by absolute EtOH (16 mL). The suspension was 
sparged with N2 for five minutes, then H2 for 5 minutes via a double-walled balloon. The 
suspension was subsequently stirred for 2 h at 20 °C under H2, sparged with N2 to remove 
excess hydrogen gas, then diluted with EtOAc (50 mL), filtered through a short pad of 
Celite and concentrated in vacuo. Purification of the crude residue by silica gel 
chromatography (slurry packed column, 4% MeOH in CHCl3) affords (+)-
anhydroryanodol (3) (94.1 mg, 0.246 mmol, 61% yield) as a colorless foam. 
 
Note: Soda-lime (Flint) disposable culture tubes were purchased from Kimble Chase and 
used during silica gel chromatography for fraction collection in order to prevent 
formation of borate complexes formed with leached B2O3 from borosilicate (Pyrex) 
glassware. In some instances, leached B2O3 from use of borosilicate glass resulted in up 
to 10% of a stable borate. Treatment with aq. 3 M KHF2 in MeOH followed by dilution 
with EtOAc and filtration over silica gel allowed for clean liberation of the reactive triol 
(as described above). The chloroform employed for silica gel chromatography contains 
0.75 % EtOH as a stabilizer. 
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TLC (10% MeOH/CH2Cl2), Rf: 0.32 (KMnO4); 1H NMR (500 MHz, CD3OD): δ 4.71 
(q, J = 2.3 Hz, 1H), 3.98 (d, J = 10.4 Hz, 1H), 3.62 (d, J = 19.9 Hz, 1H), 2.75 (hept, J = 
7.0 Hz, 1H), 2.30 (d, J = 19.8 Hz, 1H), 1.84 – 1.74 (m, 1H), 1.77 (d, J = 2.4 Hz, 3H), 
1.62 – 1.43 (m, 4H), 1.18 (s, 3H), 1.15 (d, J = 7.0 Hz, 3H), 1.11 (d, J = 7.0 Hz, 3H), 1.08 
(d, J = 6.5 Hz, 3H); 13C NMR (126 MHz, CD3OD): δ 173.2, 148.3, 134.2, 93.4, 92.8, 
90.3, 84.7, 84.0, 72.8, 48.9, 40.3, 35.2, 28.8, 28.5, 26.1, 21.6, 19.3, 18.8, 14.7, 12.2; 
FTIR (NaCl, thin film): 3450, 1735 cm-1; HRMS: calc’d for [M–H]–: 381.1919, found: 
381.2045; [α]D25: +54 (c = 0.45, MeOH). 
 
Preparation of Epianhydroryanodol Epoxide (21): 
 
Deslongchamps et. al reported the use of a 1.09 M solution of trifluoroperacetic 
acid in 1,2-dichloroethane, prepared according to the procedure of Emmons and 
Pagano.28 In this report, trifluoroperacetic acid is prepared from 90% H2O2 (aq.) and 
trifluoroacetic anhydride. Given the high hazards of preparing and handling 90% H2O2, 
which has been known detonate explosively during its preparation, we prepared 
trifluoroperacetic acid utilizing commercially available urea hydrogen peroxide. 
An approximately 1M solution of trifluoroperacetic acid was prepared according 
to the following procedure: to a 25-mL, round-bottomed flask was added urea hydrogen 
peroxide (940 mg, 10.0 mmol, 1.00 equiv) and anhydrous 1,2-dichloroethane (10.0 mL). 
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The suspension was cooled to 0 °C in an ice/water bath and trifluoroacetic anhydride 
(1.56 mL, 11 mmol, 1.1 equiv) added dropwise by syringe. The solution was stirred at 0 
°C for 1 h, then the ice bath removed and stirred at 20 °C for 1 h, by which time the white 
suspension had changed into a biphasic mixture. Stirring was stopped to allow the layers 
to separate before addition. 
 To a 100-mL, round-bottomed flask was added anhydroryanodol (76.4 mg, 0.200 
mmol, 1.00 equiv), HNa2PO4 (170 mg, 1.20 mmol, 6.0 equiv) and 1,2-dichloroethane (30 
mL). The suspension was stirred vigorously at 20 °C, then trifluoroperacetic acid (1M 
solution in 1,2-DCE, as prepared above, 0.40 mL, ~0.40 mmol, ~2 equiv) was added 
dropwise by syringe. The solution was stirred for 3 h at 20 °C, by which time TLC 
analysis had indicated consumption of the starting material, then filtered over a short pad 
of Celite to remove solids, rinsing with 1,2-dichloroethane (20 mL) and concentrated in 
vacuo to afford a white foam [Caution! Trifluoroperacetic acid, like other organic 
peroxides, is potentially explosive and should be used with caution. Although no 
incidents involving this peroxide were encountered during these studies, rotary 
evaporation was conducted behind a blast shield as a precaution]. Purification of the 
crude foam by silica gel chromatography (5% MeOH in CHCl3) afforded 
epianhydroryanodol epoxide 21 as a colorless semicrystalline solid (68.5 mg, 0.172 
mmol, 86% yield). 
Note: Soda-lime (Flint) disposable culture tubes were purchased from Kimble Chase and 
used during silica gel chromatography for fraction collection in order to prevent 
formation of borate complexes formed with leached B2O3 from borosilicate (Pyrex) 
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glassware. The chloroform employed for silica gel chromatography contains 0.75 % 
EtOH as a stabilizer. 
 
TLC (5% MeOH/CH2Cl2), Rf 0.20 (KMnO4); 1H NMR (CDCl3, 400 MHz): δ 4.58 (s, 
1H), 4.07 (d, J = 10.1 Hz, 1H), 3.66 (d, J = 16.0 Hz, 1H), 2.18 (d, J = 16.1 Hz, 1H), 1.87 
– 1.76 (m, 2H), 1.73 – 1.64 (m, 1H), 1.63 (s, 3H), 1.59 – 1.41 (m, 3H), 1.29 (ddd, J = 
13.0, 4.5, 2.1 Hz, 1H), 1.22 (d, J = 7.0 Hz, 3H), 1.06 (d, J = 7.3 Hz, 4H), 1.06 (d, J = 6.3 
Hz, 3H), 1.01 (s, 3H); 13C NMR (CDCl3, 400 MHz): 174.2, 94.7, 89.8, 89.1, 88.1, 85.1, 
77.4, 74.8, 74.3, 51.0, 38.4, 34.6, 30.6, 28.5, 24.7, 19.1, 18.3, 17.4, 17.1, 15.2; FTIR 
(NaCl, thin film): 3462, 1736 cm-1; HRMS: calc’d for [M+H]+: 399.2013, found: 
399.2034. [α]D25: –39 (c = 0.40, MeOH). 
 
Preparation of (+)-Ryanodol (2): 
 
An oven-dried, 100-mL, three-necked, round-bottomed flask containing a 
borosilicate glass-coated magnetic stirbar was equipped with an oven-dried cold-finger 
condenser and allowed to cool under dry Argon. While cooling, the flask was directly 
connected to a gas cylinder of ammonia (Matheson anhydrous ammonia) by means of a 
gas inlet adapter connected to a piece of dry Tygon tubing. Once the glassware had 
completely cooled, the flask was submerged into a dry-ice/acetone bath (–78 °C) and the 
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cold finger filled with dry-ice/acetone. Ammonia was carefully condensed into the flask 
by opening the tank, until ~50 mL had accumulated, and both the ammonia inlet and cold 
finger condenser were removed and replaced with rubber septa. Freshly cut sodium metal  
(200 mg cut into six pieces, hexanes washed) was then added piecewise to the ammonia, 
which resulted immediately in a deep blue solution. This solution was maintained at –78 
°C for 30 min for drying. 
 A separate oven-dried, 100-mL, three-necked, round-bottomed flask containing a 
borosilicate glass coated magnetic stirbar was equipped with an oven-dried cold-finger 
condenser, and was allowed to cool under an Ar atmosphere. The distilling flask prepared 
above was then connected by means of a dry piece of Tygon tubing under a positive 
pressure of Argon. The receiving flask was submerged into a dry-ice/acetone bath, and 
the cold finger condenser filled with dry ice/acetone. The distilling flask was then 
removed from the cold bath, allowing for the slow distillation of anhydrous ammonia 
from sodium metal, until ~20 mL of ammonia had condensed into the receiving flask 
(approximately 30 minutes). A solution of epianhydroryanodol epoxide (21, 15.3 mg, 
38.7 µmol, 1.0 equiv) in THF (4.0 mL) was then added dropwise by syringe to the freshly 
distilled ammonia, which was allowed to stir for an additional 15 minutes –78 °C. 
A fresh piece of lithium(0)-wire (30.5 mg, stored in mineral oil), was rinsed with 
hexanes, then cut into a pre-tared 25-mL beaker containing hexanes (15 mL). 
Immediately prior to addition, this piece of wire was further cut into four pieces (~ 7-8 
mg each) and added to the flask above within two minutes, and the deep blue mixture 
stirred for 60 min at –78 °C. Ammonium chloride (solid, 750 mg) was then added slowly 
as a solid. The deep blue color faded within 90 seconds, producing a colorless 
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suspension. The cold bath was then removed and the flask was opened to atmosphere, 
allowing for the evaporation of ammonia as the flask warmed to ambient temperature (45 
min). The resulting slurry, consisting primarily of some residual THF, LiCl, and NH4Cl 
salts, was then carefully diluted with H2O (20 mL), and additional THF (5 mL). The 
mixture was extracted with CH2Cl2 (3 x 15 mL), and the combined organics concentrated 
in vacuo. 1H NMR analysis of this organic layer indicated the presence of a carbonyl 
reduction product and a small amount of starting material.  
Carbon dioxide (g) was then bubbled through the aqueous layer (20 mL) for 10 
minutes to neutralize the pH below 8 and the aqueous layer saturated with NaCl. This 
aqueous solution was then transferred into a continuous extraction apparatus equipped 
with an efficient reflux condenser and 100 mL round bottomed flask that had been pre-
filled with CHCl3 (50 mL in the flask, 100 mL in the extraction body). The round-
bottomed flask was then heated in an oil bath at 100 °C, allowing for vigorous reflux of 
the chloroform, and the apparatus maintained for 40 h under a nitrogen atmosphere. The 
flask was then removed from the apparatus and the solvent removed in vacuo affording a 
solid residue. 1H NMR analysis of this organic residue indicated that it was ~90% pure by 
NMR. The residue was again dissolved in H2O (20 mL) and THF (5 mL) and washed 
with CH2Cl2 (3 x 15 mL). Concentration of the aqueous layer (rotovap temperature at 50 
°C) and drying under high vacuum affords (+)-ryanodol (2) as a white solid (95% purity 
by 1H NMR, 7.4 mg, 47% yield) that contains minor salt impurities and is further purified 
by silica gel chromatography (3 g of slurry packed silica, 10% MeOH in CHCl3) to afford 
ryanodol (2) as a white film (5.9 mg, 14.8 µmol, 38% yield). 
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Notes: Deslongchamps and coworkers report a detailed procedure for this 
reductive cyclization on 20 mg scale, to produce 12 mg of (+)-ryanodol, isolated in pure 
fashion directly after continuous extraction.5 In our hands, the reaction profile of this 
transformation was determined to be highly dependent on the purity of the ammonia, 
particularly with respect to trace iron impurities and water. Control experiments with 
added H2O (10 equiv) after distillation from sodium indicates that proton sources, as may 
be expected, favor the formation of carbonyl reduction products, whereas the addition of 
Fe-salts and direct condensation from the ammonia cylinder result in diminished 
reactivity, presumably due to the rapid formation of LiNH2 catalyzed by trace metal 
impurities. Fresh distillation of the ammonia to aid in drying of the solvent and removal 
of trace impurities yielded the most reproducible results. Despite these precautions, an 
identical reaction profile to that described by Deslongchamps was not obtained. 
A continuous extractor consisting of a 14/20 ground glass attachment was used 
for the extraction process. This particular extractor had a volume of approximately 120 
mL, allowing for an aqueous phase of approximately 20 mL and a heavy-organic phase 
of 100 mL. Material obtained after continuous extraction was typically of ~90% purity by 
1H NMR. Most organic impurities were readily removed by washing with THF/DCM, as 
described above. However, dissolution of this material in MeOH typically left trace 
inorganic residues (potentially trace salts from the aqueous phase) that affect an accurate 
mass.  The material obtained after column chromatography does not produce the same 
residue, lending further evidence to trace inorganic salt impurities. 
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1H NMR (CDCl3, 400 MHz): δ 4.12 (s, 1H), 3.78 (d, J = 10.2 Hz, 1H), 2.51 (d, J = 13.4 
Hz, 1H), 2.15 (hept, J = 6.7 Hz, 1H), 2.08 (td, J =12.9, 5.3 Hz, 1H), 1.90 – 1.76 (m, 1H), 
1.74 (d, J = 13.4 Hz, 1H), 1.53 (dtd, J = 12.7, 5.2, 1.6 Hz, 1H), 1.46 (qd, J = 12.9, 4.7 Hz, 
1H), 1.33 (s, 3H), 1.26 (ddd, J = 12.7, 4.6, 2.0 Hz, 1H), 1.12 (s, 3H), 1.08 (d, J = 6.8 Hz, 
3H), 1.01 (d, J = 6.5 Hz, 3H), 1.00 (d, J = 6.5 Hz, 3H). 13C NMR (CDCl3, 400 MHz): δ 
103.1, 96.3, 92.6, 91.6, 87.3, 86.6, 84.9, 72.9, 65.4, 49.7, 41.5, 35.4, 30.7, 29.4, 26.6, 
19.5, 19.4, 19.0, 13.2, 10.2; HRMS: calc’d for [M–H]–: 399.2024, found: 399.2028; 
[α]D25: +37 (c = 0.30, MeOH). 
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Comparison Tables for Authentic vs. Synthetic (+)-Ryanodol 
Table 2. Comparison of 1H NMR data for Aunthetic vs. Synthetic (+)-Ryanodol 
Inoue et al. Report32 
Authentic (+)-Ryanodol 
1H NMR, 400 MHz, CD3OD 
This Work, 
Synthetic 
(+)-Ryanodol 
1H NMR, 500 MHz, CD3OD 
δ 4.12 (s, 1H) δ 4.12 (s, 1H) 
3.77 (d, J = 10.4 Hz, 1H) 3.78 (d, J = 10.2 Hz, 1H) 
2.51 (d, J = 13.1, 1H) 2.51 (d, J = 13.4 Hz, 1H) 
2.15 (qq, J = 6.8, 6.3 Hz, 1H) 2.15 (hept, J = 6.7 Hz, 1H) 
2.08 (1H, ddd, J = 12.8, 12.8, 5.5 Hz, 1H) 2.08 (td, J =12.9, 5.3 Hz, 1H) 
1.83 (1H, ddqd, J = 13.2, 10.4, 6.3, 5.8 Hz, 1H) 1.90 – 1.76 (m, 1H) 
1.73 (d, J = 13.1 Hz, 1H) 1.74 (d, J = 13.4 Hz, 1H) 
1.51 (dddd, 13.2, 5.8, 5.5, 1.7 Hz, 1H) 1.53 (dtd, J = 12.7, 5.2, 1.6 Hz, 1H) 
1.45 (dddd, J = 13.2, 13.2, 12.8, 4.6) 1.46 (qd, J = 12.9, 4.7 Hz, 1H) 
1.33 (s, 3H) 1.33 (s, 3H) 
1.26 (ddd, J = 12.8, 4.6, 1.7 Hz, 1H) 1.26 (ddd, J = 12.7, 4.6, 2.0 Hz, 1H) 
1.12 (s, 3H) 1.12 (s, 3H) 
1.08 (d, J = 6.8, 3H) 1.08 (d, J = 6.8 Hz, 3H) 
1.01 (d, J = 6.3 Hz, 3H) 1.01 (d, J = 6.5 Hz, 3H) 
1.00 (d, J = 6.3 Hz, 3H) 1.00 (d, J = 6.5 Hz, 3H) 
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Table 3. Comparison of 13C NMR data for Authentic vs. Synthetic (+)-Ryanodol 
Inoue et al. Report,32 
 Authentic (+)-Ryanodol 
13C NMR, 100 MHz, CD3OD 
This Work, 
Synthetic 
(+)-Ryanodol 
13C NMR, 126 MHz, CD3OD 
Chemical Shift 
Difference, Δδ 
δ 103.1 δ 103.1 0 
96.3 96.3 0 
92.6 92.6 0 
91.6 91.6 0 
87.3 87.3 0 
86.6 86.6 0 
84.9 84.9 0 
72.9 72.9 0 
65.4 65.4 0 
49.6 49.7 0.1 
41.5 41.5 0 
35.4 35.4 0 
30.7 30.7 0 
29.4 29.4 0 
26.6 26.6 0 
19.5 19.5 0 
19.4 19.4 0 
19.0 19.0 0 
13.2 13.2 0 
10.2 10.2 0 
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A2.1 X-RAY STRUCTURE OF TETRACYCLE 99a 
 Crystals of 99a were grown from slow, repeated 
crystallization from Et2O and found to be suitable for X-
ray diffraction. Low-temperature diffraction data (φ-and 
ω-scans) were collected on a Bruker AXS D8 VENTURE 
KAPPA diffractometer coupled to a PHOTON 100 
CMOS detector with Cu-Kα radiation (λ = 1.54178 Å) 
from an IµS micro-source. All diffractometer 
manipulations, including data collection integration, and 
scaling were carried out using the Bruker APEXII software. Absorption corrections were 
applied using SADABS.2 The structure was solved by intrinsic phasing using SHELXT and 
refined against F2 on all data by full-matrix least squares with SHELXL-2014 using 
established refinement techniques and with an extinction correction of 0.00106(15). All non-
hydrogen atoms were refined using anisotropic displacement parameters. All hydrogen atoms 
were included into the model at geometrically calculated positions and refined using a riding 
model. Compound 99a crystallizes in the orthorhombic space group P212121 and absolute 
configuration was determined by anomalous dispersion (Flack = -0.02(8)). CCDC deposition 
number 1478621 contains the supplementary crystallographic data for 99a. This data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
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www.ccdc.cam.ac.uk/data_request/cif. 
 
Table A.2.1.  Crystal data and structure refinement for p16083_O_a. 
 
Identification code  p16083_o_a 
Empirical formula  C33 H38 O7 
Formula weight  546.63 
Temperature  100 K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.5193(3) Å α= 90°. 
 b = 9.9691(4) Å β= 90°. 
 c = 37.1447(17) Å γ = 90°. 
Volume 2784.4(2) Å3 
Z 4 
Density (calculated) 1.304 Mg/m3 
Absorption coefficient 0.735 mm-1 
F(000) 1168 
Crystal size 0.22 x 0.15 x 0.12 mm3 
Theta range for data collection 2.379 to 78.722°. 
Index ranges -9<=h<=8, -11<=k<=12, -44<=l<=46 
Reflections collected 25520 
Independent reflections 5891 [R(int) = 0.0654] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7542 and 0.6748 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5891 / 0 / 369 
Goodness-of-fit on F2 1.054 
Final R indices [I>2sigma(I)] R1 = 0.0332, wR2 = 0.0756 
R indices (all data) R1 = 0.0395, wR2 = 0.0783 
Absolute structure parameter -0.02(8) 
Extinction coefficient 0.00106(15) 
Largest diff. peak and hole 0.388 and -0.305 e.Å-3 
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Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for p16083_O_a.  U(eq) is defined as one third of  the trace of 
the orthogonalized Uij tensor. 
___________________________________________________________________________ 
 x y z U(eq) 
___________________________________________________________________________ 
O(4) 2446(2) 7582(1) 3543(1) 18(1) 
O(3) 4(2) 4472(1) 3389(1) 16(1) 
O(5) 3759(2) 9341(2) 3828(1) 21(1) 
O(6) 2900(2) 3729(1) 3863(1) 17(1) 
O(7) 5698(2) 4343(2) 4094(1) 20(1) 
O(2) -2174(2) 3906(2) 3026(1) 27(1) 
O(1) 4183(3) 3802(2) 2313(1) 34(1) 
C(10) 2201(3) 5059(2) 3829(1) 15(1) 
C(29) 6237(3) 5835(2) 4718(1) 20(1) 
C(15) -1057(3) 4716(2) 3102(1) 18(1) 
C(28) 6510(3) 4451(2) 4716(1) 18(1) 
C(9) 664(3) 5251(2) 4097(1) 17(1) 
C(16) 4771(3) 3678(2) 3818(1) 20(1) 
C(6) 919(3) 6838(2) 3422(1) 16(1) 
C(12) 2662(3) 5171(2) 3110(1) 16(1) 
C(5) 684(3) 6979(2) 3008(1) 19(1) 
C(33) 7460(3) 3870(2) 4998(1) 22(1) 
C(1) 3222(3) 4090(2) 2927(1) 19(1) 
C(22) 6786(3) 10036(2) 3812(1) 24(1) 
C(4) 2507(3) 6424(2) 2883(1) 20(1) 
C(14) -850(3) 6035(2) 2901(1) 20(1) 
C(31) 7840(3) 6022(2) 5278(1) 24(1) 
C(19) 5755(3) 3586(2) 4421(1) 21(1) 
C(11) 1544(3) 5350(2) 3447(1) 14(1) 
C(7) -659(3) 7050(2) 3672(1) 18(1) 
C(30) 6905(3) 6619(2) 4997(1) 23(1) 
C(27) 7190(3) 9695(2) 4167(1) 26(1) 
C(21) 1297(3) 5035(2) 4483(1) 22(1) 
C(32) 8119(3) 4649(2) 5278(1) 24(1) 
C(2) 3570(3) 4510(2) 2549(1) 23(1) 
C(8) -140(3) 6662(2) 4058(1) 20(1) 
C(3) 2884(3) 5936(2) 2500(1) 25(1) 
C(25) 9588(3) 11287(2) 4169(1) 28(1) 
C(23) 7809(3) 10996(2) 3640(1) 24(1) 
C(20) 311(3) 8385(2) 2862(1) 26(1) 
C(17) 3378(3) 2659(2) 3039(1) 23(1) 
C(24) 9198(3) 11617(2) 3817(1) 26(1) 
C(26) 8583(3) 10318(2) 4347(1) 27(1) 
C(13) 2247(3) 8959(2) 3642(1) 28(1) 
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C(18) 5294(3) 9365(3) 3607(1) 33(1) 
 
 
Table 3.   Bond lengths [Å] and angles [°] for  p16083_O_a. 
_____________________________________________________  
O(4)-C(6)  1.439(2) 
O(4)-C(13)  1.429(2) 
O(3)-C(15)  1.354(2) 
O(3)-C(11)  1.467(2) 
O(5)-C(13)  1.384(3) 
O(5)-C(18)  1.416(3) 
O(6)-C(10)  1.432(2) 
O(6)-C(16)  1.418(3) 
O(7)-C(16)  1.406(2) 
O(7)-C(19)  1.430(2) 
O(2)-C(15)  1.199(3) 
O(1)-C(2)  1.217(3) 
C(10)-H(10)  1.0000 
C(10)-C(9)  1.536(3) 
C(10)-C(11)  1.532(3) 
C(29)-H(29)  0.9500 
C(29)-C(28)  1.395(3) 
C(29)-C(30)  1.391(3) 
C(15)-C(14)  1.521(3) 
C(28)-C(33)  1.393(3) 
C(28)-C(19)  1.507(3) 
C(9)-C(21)  1.528(3) 
C(9)-C(8)  1.537(3) 
C(9)-H(9)  0.94(3) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(6)-C(5)  1.556(3) 
C(6)-C(11)  1.559(3) 
C(6)-C(7)  1.521(3) 
C(12)-C(1)  1.340(3) 
C(12)-C(4)  1.511(3) 
C(12)-C(11)  1.518(3) 
C(5)-C(4)  1.549(3) 
C(5)-C(14)  1.541(3) 
C(5)-C(20)  1.528(3) 
C(33)-H(33)  0.9500 
C(33)-C(32)  1.387(3) 
C(1)-C(2)  1.490(3) 
C(1)-C(17)  1.491(3) 
C(22)-C(27)  1.397(3) 
C(22)-C(23)  1.384(3) 
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C(22)-C(18)  1.510(3) 
C(4)-H(4)  1.0000 
C(4)-C(3)  1.529(3) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(31)-H(31)  0.9500 
C(31)-C(30)  1.390(3) 
C(31)-C(32)  1.385(3) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(7)-C(8)  1.537(3) 
C(30)-H(30)  0.9500 
C(27)-H(27)  0.9500 
C(27)-C(26)  1.389(3) 
C(21)-H(21A)  0.9800 
C(21)-H(21B)  0.9800 
C(21)-H(21C)  0.9800 
C(32)-H(32)  0.9500 
C(2)-C(3)  1.523(3) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(3)-H(3A)  0.9900 
C(3)-H(3B)  0.9900 
C(25)-H(25)  0.9500 
C(25)-C(24)  1.379(3) 
C(25)-C(26)  1.392(3) 
C(23)-H(23)  0.9500 
C(23)-C(24)  1.381(3) 
C(20)-H(20A)  0.9800 
C(20)-H(20B)  0.9800 
C(20)-H(20C)  0.9800 
C(17)-H(17A)  0.9800 
C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(24)-H(24)  0.9500 
C(26)-H(26)  0.9500 
C(13)-H(13A)  0.9900 
C(13)-H(13B)  0.9900 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(13)-O(4)-C(6) 119.45(16) 
C(15)-O(3)-C(11) 118.19(15) 
C(13)-O(5)-C(18) 112.66(18) 
C(16)-O(6)-C(10) 112.76(15) 
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C(16)-O(7)-C(19) 112.65(16) 
O(6)-C(10)-H(10) 108.6 
O(6)-C(10)-C(9) 109.59(15) 
O(6)-C(10)-C(11) 111.99(15) 
C(9)-C(10)-H(10) 108.6 
C(11)-C(10)-H(10) 108.6 
C(11)-C(10)-C(9) 109.48(16) 
C(28)-C(29)-H(29) 119.8 
C(30)-C(29)-H(29) 119.8 
C(30)-C(29)-C(28) 120.5(2) 
O(3)-C(15)-C(14) 118.85(18) 
O(2)-C(15)-O(3) 118.52(19) 
O(2)-C(15)-C(14) 122.55(19) 
C(29)-C(28)-C(19) 120.96(19) 
C(33)-C(28)-C(29) 118.8(2) 
C(33)-C(28)-C(19) 120.19(19) 
C(10)-C(9)-C(8) 110.51(16) 
C(10)-C(9)-H(9) 108.2(15) 
C(21)-C(9)-C(10) 110.86(17) 
C(21)-C(9)-C(8) 109.77(16) 
C(21)-C(9)-H(9) 108.1(15) 
C(8)-C(9)-H(9) 109.4(15) 
O(6)-C(16)-H(16A) 109.0 
O(6)-C(16)-H(16B) 109.0 
O(7)-C(16)-O(6) 112.95(17) 
O(7)-C(16)-H(16A) 109.0 
O(7)-C(16)-H(16B) 109.0 
H(16A)-C(16)-H(16B) 107.8 
O(4)-C(6)-C(5) 110.72(16) 
O(4)-C(6)-C(11) 103.40(15) 
O(4)-C(6)-C(7) 111.10(16) 
C(5)-C(6)-C(11) 100.27(15) 
C(7)-C(6)-C(5) 120.16(17) 
C(7)-C(6)-C(11) 109.33(16) 
C(1)-C(12)-C(4) 114.03(17) 
C(1)-C(12)-C(11) 133.24(19) 
C(4)-C(12)-C(11) 108.62(17) 
C(4)-C(5)-C(6) 99.35(16) 
C(14)-C(5)-C(6) 106.56(16) 
C(14)-C(5)-C(4) 111.53(17) 
C(20)-C(5)-C(6) 116.95(17) 
C(20)-C(5)-C(4) 112.65(18) 
C(20)-C(5)-C(14) 109.38(18) 
C(28)-C(33)-H(33) 119.6 
C(32)-C(33)-C(28) 120.8(2) 
C(32)-C(33)-H(33) 119.6 
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C(12)-C(1)-C(2) 107.81(19) 
C(12)-C(1)-C(17) 130.82(19) 
C(2)-C(1)-C(17) 121.18(18) 
C(27)-C(22)-C(18) 121.9(2) 
C(23)-C(22)-C(27) 118.9(2) 
C(23)-C(22)-C(18) 119.2(2) 
C(12)-C(4)-C(5) 101.40(16) 
C(12)-C(4)-H(4) 108.9 
C(12)-C(4)-C(3) 103.95(17) 
C(5)-C(4)-H(4) 108.9 
C(3)-C(4)-C(5) 123.74(19) 
C(3)-C(4)-H(4) 108.9 
C(15)-C(14)-C(5) 118.56(17) 
C(15)-C(14)-H(14A) 107.7 
C(15)-C(14)-H(14B) 107.7 
C(5)-C(14)-H(14A) 107.7 
C(5)-C(14)-H(14B) 107.7 
H(14A)-C(14)-H(14B) 107.1 
C(30)-C(31)-H(31) 120.0 
C(32)-C(31)-H(31) 120.0 
C(32)-C(31)-C(30) 120.0(2) 
O(7)-C(19)-C(28) 109.14(17) 
O(7)-C(19)-H(19A) 109.9 
O(7)-C(19)-H(19B) 109.9 
C(28)-C(19)-H(19A) 109.9 
C(28)-C(19)-H(19B) 109.9 
H(19A)-C(19)-H(19B) 108.3 
O(3)-C(11)-C(10) 106.06(15) 
O(3)-C(11)-C(6) 108.76(15) 
O(3)-C(11)-C(12) 104.30(15) 
C(10)-C(11)-C(6) 109.37(15) 
C(12)-C(11)-C(10) 124.31(17) 
C(12)-C(11)-C(6) 103.31(16) 
C(6)-C(7)-H(7A) 109.7 
C(6)-C(7)-H(7B) 109.7 
C(6)-C(7)-C(8) 109.69(17) 
H(7A)-C(7)-H(7B) 108.2 
C(8)-C(7)-H(7A) 109.7 
C(8)-C(7)-H(7B) 109.7 
C(29)-C(30)-H(30) 120.0 
C(31)-C(30)-C(29) 120.0(2) 
C(31)-C(30)-H(30) 120.0 
C(22)-C(27)-H(27) 119.7 
C(26)-C(27)-C(22) 120.6(2) 
C(26)-C(27)-H(27) 119.7 
C(9)-C(21)-H(21A) 109.5 
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C(9)-C(21)-H(21B) 109.5 
C(9)-C(21)-H(21C) 109.5 
H(21A)-C(21)-H(21B) 109.5 
H(21A)-C(21)-H(21C) 109.5 
H(21B)-C(21)-H(21C) 109.5 
C(33)-C(32)-H(32) 120.0 
C(31)-C(32)-C(33) 120.0(2) 
C(31)-C(32)-H(32) 120.0 
O(1)-C(2)-C(1) 125.7(2) 
O(1)-C(2)-C(3) 125.8(2) 
C(1)-C(2)-C(3) 108.36(17) 
C(9)-C(8)-H(8A) 108.6 
C(9)-C(8)-H(8B) 108.6 
C(7)-C(8)-C(9) 114.61(16) 
C(7)-C(8)-H(8A) 108.6 
C(7)-C(8)-H(8B) 108.6 
H(8A)-C(8)-H(8B) 107.6 
C(4)-C(3)-H(3A) 110.9 
C(4)-C(3)-H(3B) 110.9 
C(2)-C(3)-C(4) 104.41(17) 
C(2)-C(3)-H(3A) 110.9 
C(2)-C(3)-H(3B) 110.9 
H(3A)-C(3)-H(3B) 108.9 
C(24)-C(25)-H(25) 120.0 
C(24)-C(25)-C(26) 120.0(2) 
C(26)-C(25)-H(25) 120.0 
C(22)-C(23)-H(23) 119.7 
C(24)-C(23)-C(22) 120.6(2) 
C(24)-C(23)-H(23) 119.7 
C(5)-C(20)-H(20A) 109.5 
C(5)-C(20)-H(20B) 109.5 
C(5)-C(20)-H(20C) 109.5 
H(20A)-C(20)-H(20B) 109.5 
H(20A)-C(20)-H(20C) 109.5 
H(20B)-C(20)-H(20C) 109.5 
C(1)-C(17)-H(17A) 109.5 
C(1)-C(17)-H(17B) 109.5 
C(1)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(25)-C(24)-C(23) 120.4(2) 
C(25)-C(24)-H(24) 119.8 
C(23)-C(24)-H(24) 119.8 
C(27)-C(26)-C(25) 119.4(2) 
C(27)-C(26)-H(26) 120.3 
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C(25)-C(26)-H(26) 120.3 
O(4)-C(13)-H(13A) 110.1 
O(4)-C(13)-H(13B) 110.1 
O(5)-C(13)-O(4) 107.86(18) 
O(5)-C(13)-H(13A) 110.1 
O(5)-C(13)-H(13B) 110.1 
H(13A)-C(13)-H(13B) 108.4 
O(5)-C(18)-C(22) 108.78(18) 
O(5)-C(18)-H(18A) 109.9 
O(5)-C(18)-H(18B) 109.9 
C(22)-C(18)-H(18A) 109.9 
C(22)-C(18)-H(18B) 109.9 
H(18A)-C(18)-H(18B) 108.3 
 
Table A.2.4.   Anisotropic displacement parameters  (Å2x 103) for p16083_O_a.  The 
anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  + 2 h 
k a* b* U12 ] 
_________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
_________________________________________________________________ 
O(4) 17(1)  11(1) 24(1)  -3(1) -1(1)  -1(1) 
O(3) 15(1)  16(1) 16(1)  0(1) -1(1)  -3(1) 
O(5) 18(1)  19(1) 24(1)  -6(1) 2(1)  -3(1) 
O(6) 18(1)  14(1) 19(1)  -1(1) -1(1)  2(1) 
O(7) 21(1)  23(1) 16(1)  -1(1) -4(1)  2(1) 
O(2) 27(1)  30(1) 25(1)  0(1) -6(1)  -12(1) 
O(1) 36(1)  46(1) 19(1)  -9(1) 4(1)  11(1) 
C(10) 15(1)  14(1) 16(1)  -2(1) 0(1)  1(1) 
C(29) 19(1)  21(1) 20(1)  1(1) -2(1)  3(1) 
C(15) 17(1)  22(1) 15(1)  -2(1) 1(1)  -1(1) 
C(28) 17(1)  20(1) 17(1)  1(1) 0(1)  -1(1) 
C(9) 18(1)  18(1) 15(1)  -2(1) 1(1)  -1(1) 
C(16) 18(1)  22(1) 18(1)  -5(1) -2(1)  6(1) 
C(6) 15(1)  15(1) 17(1)  -2(1) -1(1)  -1(1) 
C(12) 14(1)  19(1) 16(1)  -1(1) 0(1)  -2(1) 
C(5) 22(1)  16(1) 17(1)  2(1) -1(1)  -1(1) 
C(33) 22(1)  22(1) 22(1)  4(1) -2(1)  1(1) 
C(1) 18(1)  23(1) 17(1)  -4(1) 2(1)  1(1) 
C(22) 18(1)  23(1) 30(1)  -13(1) 4(1)  3(1) 
C(4) 22(1)  19(1) 17(1)  0(1) 2(1)  -4(1) 
C(14) 23(1)  22(1) 16(1)  1(1) -2(1)  0(1) 
C(31) 22(1)  32(1) 17(1)  -5(1) 1(1)  -3(1) 
C(19) 24(1)  19(1) 20(1)  1(1) -5(1)  2(1) 
C(11) 14(1)  13(1) 16(1)  -2(1) 1(1)  -2(1) 
C(7) 17(1)  18(1) 20(1)  -4(1) 0(1)  3(1) 
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C(30) 25(1)  22(1) 24(1)  -3(1) 2(1)  1(1) 
C(27) 25(1)  18(1) 34(1)  -4(1) 8(1)  1(1) 
C(21) 24(1)  27(1) 16(1)  -2(1) 2(1)  1(1) 
C(32) 21(1)  34(1) 16(1)  3(1) -3(1)  -2(1) 
C(2) 18(1)  32(1) 18(1)  -4(1) 2(1)  -1(1) 
C(8) 19(1)  22(1) 19(1)  -3(1) 5(1)  5(1) 
C(3) 30(1)  28(1) 17(1)  1(1) 6(1)  -3(1) 
C(25) 21(1)  23(1) 39(1)  -5(1) -7(1)  0(1) 
C(23) 22(1)  21(1) 28(1)  -3(1) 0(1)  6(1) 
C(20) 35(1)  20(1) 23(1)  6(1) -1(1)  0(1) 
C(17) 27(1)  22(1) 21(1)  -7(1) 0(1)  7(1) 
C(24) 25(1)  16(1) 37(1)  0(1) 2(1)  1(1) 
C(26) 26(1)  25(1) 29(1)  1(1) -2(1)  7(1) 
C(13) 24(1)  15(1) 46(1)  -7(1) -6(1)  0(1) 
C(18) 26(1)  42(1) 31(1)  -16(1) 9(1)  -9(1) 
 
Table A.2.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2x 10 3) for p16083_O_a. 
___________________________________________________________________________
 x  y  z  U(eq) 
___________________________________________________________________________ 
  
H(10) 3165 5713 3890 18 
H(29) 5591 6245 4528 24 
H(16A) 5153 2728 3811 23 
H(16B) 5086 4090 3584 23 
H(33) 7660 2929 4999 26 
H(4) 3460 7067 2956 24 
H(14A) -1976 6540 2927 24 
H(14B) -715 5823 2642 24 
H(31) 8288 6556 5469 29 
H(19A) 6507 2780 4388 25 
H(19B) 4541 3288 4486 25 
H(7A) -1673 6492 3591 22 
H(7B) -1032 8002 3665 22 
H(30) 6721 7562 4996 28 
H(27) 6506 9030 4287 31 
H(21A) 1624 4092 4517 33 
H(21B) 339 5271 4651 33 
H(21C) 2334 5605 4530 33 
H(32) 8761 4240 5469 28 
H(8A) -1211 6719 4213 24 
H(8B) 731 7325 4149 24 
H(3A) 1787 5946 2353 30 
H(3B) 3791 6507 2383 30 
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H(25) 10541 11720 4290 33 
H(23) 7554 11230 3397 29 
H(20A) -674 8787 2998 39 
H(20B) -10 8328 2607 39 
H(20C) 1376 8942 2889 39 
H(17A) 4612 2466 3107 35 
H(17B) 3028 2077 2838 35 
H(17C) 2597 2491 3245 35 
H(24) 9888 12275 3696 31 
H(26) 8849 10086 4589 32 
H(13A) 2100 9520 3424 34 
H(13B) 1182 9074 3796 34 
H(18A) 5044 9865 3383 40 
H(18B) 5641 8438 3542 40 
H(9) -210(30) 4610(20) 4046(6) 17(6) 
___________________________________________________________ 
 
 
Table A.2.6.  Torsion angles [°] for p16083_O_a. 
________________________________________________________________  
O(4)-C(6)-C(5)-C(4) 58.24(19) 
O(4)-C(6)-C(5)-C(14) 174.15(16) 
O(4)-C(6)-C(5)-C(20) -63.2(2) 
O(4)-C(6)-C(11)-O(3) 170.36(14) 
O(4)-C(6)-C(11)-C(10) 54.95(19) 
O(4)-C(6)-C(11)-C(12) -79.25(17) 
O(4)-C(6)-C(7)-C(8) -56.4(2) 
O(3)-C(15)-C(14)-C(5) 6.1(3) 
O(6)-C(10)-C(9)-C(21) 59.6(2) 
O(6)-C(10)-C(9)-C(8) -178.50(15) 
O(6)-C(10)-C(11)-O(3) 66.60(19) 
O(6)-C(10)-C(11)-C(6) -176.28(15) 
O(6)-C(10)-C(11)-C(12) -53.9(2) 
O(2)-C(15)-C(14)-C(5) -177.2(2) 
O(1)-C(2)-C(3)-C(4) -172.6(2) 
C(10)-O(6)-C(16)-O(7) 66.2(2) 
C(10)-C(9)-C(8)-C(7) 51.7(2) 
C(29)-C(28)-C(33)-C(32) 0.3(3) 
C(29)-C(28)-C(19)-O(7) 31.6(3) 
C(15)-O(3)-C(11)-C(10) 166.62(15) 
C(15)-O(3)-C(11)-C(6) 49.1(2) 
C(15)-O(3)-C(11)-C(12) -60.6(2) 
C(28)-C(29)-C(30)-C(31) -0.5(3) 
C(28)-C(33)-C(32)-C(31) -0.3(3) 
C(9)-C(10)-C(11)-O(3) -55.16(19) 
C(9)-C(10)-C(11)-C(6) 61.96(19) 
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C(9)-C(10)-C(11)-C(12) -175.67(17) 
C(16)-O(6)-C(10)-C(9) -143.36(17) 
C(16)-O(6)-C(10)-C(11) 94.94(19) 
C(16)-O(7)-C(19)-C(28) -171.20(17) 
C(6)-O(4)-C(13)-O(5) 165.61(17) 
C(6)-C(5)-C(4)-C(12) 46.43(18) 
C(6)-C(5)-C(4)-C(3) 161.92(18) 
C(6)-C(5)-C(14)-C(15) -35.0(2) 
C(6)-C(7)-C(8)-C(9) -52.8(2) 
C(12)-C(1)-C(2)-O(1) 175.9(2) 
C(12)-C(1)-C(2)-C(3) -8.8(2) 
C(12)-C(4)-C(3)-C(2) -10.5(2) 
C(5)-C(6)-C(11)-O(3) -75.25(17) 
C(5)-C(6)-C(11)-C(10) 169.34(16) 
C(5)-C(6)-C(11)-C(12) 35.13(18) 
C(5)-C(6)-C(7)-C(8) 172.11(17) 
C(5)-C(4)-C(3)-C(2) -124.8(2) 
C(33)-C(28)-C(19)-O(7) -150.05(19) 
C(1)-C(12)-C(4)-C(5) 135.25(18) 
C(1)-C(12)-C(4)-C(3) 5.9(2) 
C(1)-C(12)-C(11)-O(3) -47.8(3) 
C(1)-C(12)-C(11)-C(10) 73.5(3) 
C(1)-C(12)-C(11)-C(6) -161.5(2) 
C(1)-C(2)-C(3)-C(4) 12.0(2) 
C(22)-C(27)-C(26)-C(25) -0.3(3) 
C(22)-C(23)-C(24)-C(25) 0.1(3) 
C(4)-C(12)-C(1)-C(2) 1.7(2) 
C(4)-C(12)-C(1)-C(17) -173.2(2) 
C(4)-C(12)-C(11)-O(3) 107.26(18) 
C(4)-C(12)-C(11)-C(10) -131.43(19) 
C(4)-C(12)-C(11)-C(6) -6.4(2) 
C(4)-C(5)-C(14)-C(15) 72.4(2) 
C(14)-C(5)-C(4)-C(12) -65.6(2) 
C(14)-C(5)-C(4)-C(3) 49.9(3) 
C(19)-O(7)-C(16)-O(6) 76.3(2) 
C(19)-C(28)-C(33)-C(32) -178.1(2) 
C(11)-O(3)-C(15)-O(2) 170.39(18) 
C(11)-O(3)-C(15)-C(14) -12.7(2) 
C(11)-C(10)-C(9)-C(21) -177.25(16) 
C(11)-C(10)-C(9)-C(8) -55.3(2) 
C(11)-C(6)-C(5)-C(4) -50.44(17) 
C(11)-C(6)-C(5)-C(14) 65.47(19) 
C(11)-C(6)-C(5)-C(20) -171.89(19) 
C(11)-C(6)-C(7)-C(8) 57.1(2) 
C(11)-C(12)-C(1)-C(2) 155.8(2) 
C(11)-C(12)-C(1)-C(17) -19.2(4) 
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C(11)-C(12)-C(4)-C(5) -25.1(2) 
C(11)-C(12)-C(4)-C(3) -154.45(17) 
C(7)-C(6)-C(5)-C(4) -170.07(17) 
C(7)-C(6)-C(5)-C(14) -54.2(2) 
C(7)-C(6)-C(5)-C(20) 68.5(3) 
C(7)-C(6)-C(11)-O(3) 52.0(2) 
C(7)-C(6)-C(11)-C(10) -63.5(2) 
C(7)-C(6)-C(11)-C(12) 162.34(16) 
C(30)-C(29)-C(28)-C(33) 0.0(3) 
C(30)-C(29)-C(28)-C(19) 178.5(2) 
C(30)-C(31)-C(32)-C(33) -0.2(4) 
C(27)-C(22)-C(23)-C(24) -0.6(3) 
C(27)-C(22)-C(18)-O(5) 47.4(3) 
C(21)-C(9)-C(8)-C(7) 174.31(18) 
C(32)-C(31)-C(30)-C(29) 0.5(4) 
C(23)-C(22)-C(27)-C(26) 0.7(3) 
C(23)-C(22)-C(18)-O(5) -134.1(2) 
C(20)-C(5)-C(4)-C(12) 170.93(17) 
C(20)-C(5)-C(4)-C(3) -73.6(3) 
C(20)-C(5)-C(14)-C(15) -162.34(18) 
C(17)-C(1)-C(2)-O(1) -8.6(4) 
C(17)-C(1)-C(2)-C(3) 166.7(2) 
C(24)-C(25)-C(26)-C(27) -0.2(3) 
C(26)-C(25)-C(24)-C(23) 0.3(3) 
C(13)-O(4)-C(6)-C(5) 88.7(2) 
C(13)-O(4)-C(6)-C(11) -164.68(18) 
C(13)-O(4)-C(6)-C(7) -47.5(2) 
C(13)-O(5)-C(18)-C(22) 169.40(19) 
C(18)-O(5)-C(13)-O(4) 67.5(2) 
C(18)-C(22)-C(27)-C(26) 179.2(2) 
C(18)-C(22)-C(23)-C(24) -179.2(2) 
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